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EXPLANATION OF THESIS FORMAT 
The following thesis consists of a general introduction, a review of 
Salmonella vaccination submitted for publication, three manuscripts, a 
general summary, and acknowledgements. The doctor of philosophy 
candidate, Michael B. Roof, is the senior author and principal investigator 
for these manuscripts. 
INTRODUCTION 
Salmonella sfî. are gram-negative, nonspore-forming, facultative 
intracellular bacteria belonging to the family Enterobacteriaceae. 
Classification of Salmonella is based on agglutination of the somatic (0) and 
flagellar (H) antigens. There are over 1800 serotypes of Salmonella. The 
serotype of an isolate is commonly used as a species designation. 
S. choleraesuis var. kunzendorf causes the septicemic disease swine 
paratyphoid and is the most frequent Salmonella serotype associated with 
disease in swine. Swine paratyphoid is estimated to be responsible for over 
$100 million dollars in economic loss for swine producers annually. 
Salmonella tvohimurium is also a common pathogen of swine causing 
predominately diarrhea. 
Salmonella normally is taken up by the host by ingestion. It invades 
the intestinal epithelium, survives the host immune response, and 
disseminates to peripheral organs. Salmonella infection may be septicemic 
and kill the host. Phagocytic cells, especially neutrophils, arrive in large 
numbers at sites of infection, and may destroy avirulent Salmonella or low 
numbers of virulent Salmonella. 
Salmonella are facultative intracellular pathogens and are able to resist 
phagocyte killing by inhibition of the oxidative response, prevention of 
phagosome-lysosome fusion, resistance to lysosomal contents, or inhibition 
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of ingestion. Many of these resistance mechanisms are induced only in the 
presence of environmental stimuli, and their expression is coordinately 
regulated. It has been demonstrated that clinically healthy pigs were carriers 
of Salmonella. Examination at slaughter indicates that Salmonella can 
routinely be isolated from the lymph nodes and tonsils of apparently healthy 
pigs. At the present time there are not adequate vaccines available for 
protection of swine against salmonellosis or techniques for the identification 
of carrier animals. 
The purposes of this investigation were to 1 ) examine changes in &. 
choleraesuis after neutrophil exposure, 2) examine the role the neutrophil 
may play as a reservoir in carrier animals, and 3) determine the outer 
membrane proteins involved in phagocyte resistance and invasion. 
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SECTION 1: IMMUNITY AND VACCINATION AGAINST SALMONELLOSIS 
IN SWINE 
5 
IMMUNITY AND VACCINATION AGAINST SALMONELLOSIS 
IN SWINE 
Submitted by 
M. B. Roof, J. A. Rotli, and T. T. Kramer 
Department of Microbiology, Immunology, 
and Preventive Medicine 
Iowa State University 
Ames, Iowa 
(U.S.A.) 
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GENERAL CHARACTERISTICS OF SALMONELLA 
Classification 
Salmonella so. are non-spore-forming, gram-negative, facultative 
intracellular bacteria, belonging to the family Enterobacteriaceae. At the 
present time, there are three species of Salmonella: typhi and 
choleraesuis each consist of a single serotype, and all other Salmonella are 
grouped by serotype under S- enteritidis (54). 
DNA-DNA hybridization has demonstrated that Salmonella are so 
closely related that there is no species differentiation. Despite this close 
relationship, there are over 1800 serotypes which differ in antigenic 
structure, host adaptation, biochemical reactions and geographic distribution 
(37). Although the nomenclature is confusing, the serotype of each 
subspecies is generally used to identify isolates as species (37). 
Salmonella group classification in the Kauffman-White scheme is by 
agglutination of somatic (0) antigens. These somatic antigens are the 
lipopolysaccharide (LPS) components of the cell wall (37). Each group has a 
major and several minor antigens which allow its classification. Serotypes 
are also based on flagellar (H) antigens which may occur as either phase 1 or 
2. Salmonella typhi has an additional Vi antigen which blocks agglutination 
of the 0 antigens (37). 
antibiotic susceptibility, 
(37). 
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Salmonella have also been characterized by 
bacteriophage typing, and plasmid fingerprinting 
Epidemiology 
Salmonella have been isolated from all vertebrates that have been 
examined, and has been called the "universal pathogen" (103). Infected 
animals are the principal source of nontyphoidal Salmonella that infect man 
(103). 
Some Salmonella are highly host-adapted for example, S- tvohi. S. 
choleraesuis. S. aallinarum-pullorum. S. dublin. S. abortus ovis. and S. 
abortus eoui are often associated with man, pigs, poultry, cattle, sheep, and 
horses, respectively (37). Beside S- choleraesuis. other serotypes commonly 
isolated from swine include §. derbv. S- tvphimurium. §. aaona. and S. 
tvohi-suis (1). Despite their degree of species specificity, many Salmonella 
can produce disease in both animals and man (37). 
Salmonella contamination of processed pork can occur by a variety of 
mechanisms. Prior to the slaughter process, pigs are crowded and stressed 
which promotes cross-contamination. During the slaughter process. 
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contaminated dehairing machines, scalding tanks, and polishers can facilitate 
the spread of Salmonella (86,103). 
Salmonellosis in pigs is due primarily to £• tvohimurium and 
S. choleraesuis. The disease occurs mostly among intensively reared 
weaned pigs less than four months of age. The disease in suckling pigs is 
rare because of lactogenic immunity (103). S- choleraesuis is the most 
frequent isolate from feeder pigs. During the acute phase of the disease, 
pigs may shed from 10'-10' S. tvohimurium per gram of feces (103). The 
dose of bacteria required to produce disease has not been critically defined, 
but ranges from 10®-10" have been reported (103). The actual infectious 
dose depends on factors such as gastric acidity, animal density, stress, and 
genetic susceptibility of the pigs (103). Swine are frequently exposed to 
low levels of a variety of Salmonella serotypes in food, water and feces. 
Salmonella can establish a subclinical or asymptomatic infection, which 
becomes clinically important upon stress of the animal (103). 
Pathogenesis 
The pathogenesis of Salmonellosis has been studied and 
characterized, but the pathogenesis of choleraesuis in swine has received 
little attention. Most studies have been conducted using laboratory animals 
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and cell cultures, and have questionable relevance to salmonellosis in swine 
(103). 
Salmonellae are normally introduced orally, pass through the stomach, 
and surviving bacteria then colonize the intestine (32). Intraluminal 
replication varies with the serotype; g. tvohimurium replicates to a greater 
extent intraluminally than the inherently invasive S. choleraesuis (103). 
Salmonellae then pass through the glycocalyx and attach to the villus tips of 
intestinal epithelium (19,32). 
Invasion of the intestinal epithelium by enteroinvasive bacteria has 
been thoroughly reviewed (16,19,30,80,102). Briefly, the uptake by 
endocytosis is performed by the host cells. Attachment of the bacteria to 
epithelial receptors triggers microfilament controlled uptake and vacuole 
formation (32,80). Salmonellae remain in the vacuole and are transported 
through the cell cytoplasm and enter the lamina propria via exocytosis 
through the basement membrane (19,32). Invasion has also been shown to 
occur by uptake through M cells of the Peyer's patches. Some investigators 
suggest that uptake by Peyer's patches may be the primary site of bacterial 
invasion (71). Macrophages have also been shown to ingest intraluminal 
bacteria, pass through breaks in the basement membrane, and enter the 
lamina propria (102). 
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The pathogenesis of diarrhea caused by Salmonella is normally due to 
malabsorption and fluid leakage from the inflamed bowel (25). Phagocytic 
cells accumulate in large numbers after invasion. These phagocytic cells 
release toxic components which cause tissue damage and inflammation. 
The net result is a decrease in sodium ion resorption and chloride ion 
secretion leading to fluid loss (25). Additionally, the diarrhea may be caused 
by an enterotoxin similar to that described for Escherichia coli or Vibrio 
cholerae (30). The Saimonelia-enterocyte interaction may also result in the 
release of prostaglandins and adenylate cyclase which stimulate the 
production of cyclic adenosine monophosphate (cAMP) and secretion (25). 
Once in the lamina propria, the bacteria are exposed to large numbers 
of phagocytic cells, including neutrophils and macrophages associated with 
the gut-associated lymphoid tissue (GALT) (101). The GALT is made up of 
lymphoid tissue under the lamina propria including Peyer's patches, lymphoid 
follicles, intraepithelial lymphocytes, and mesenteric lymph nodes (101). 
Ingestion of salmonellae by phagocytic cells allows killing of many of the 
invading bacteria, but some manage to survive. Salmonella are facultative 
intracellular pathogens which can survive for extended periods inside 
phagocytic cells (2,15). Once inside phagocytes, the intracellular bacteria 
are protected from extracellular killing and may also use the phagocyte for 
protected dissemination to other sites (2). 
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With the spread of salmonellae to deeper tissues, the systemic signs 
and lesions of septicemia are mainly due to the effects of endotoxin. The 
biologic effects of endotoxin have been extensively reviewed, and include 
activation of complement, intravascular coagulation, inflammation, 
aggregation of platelets, alterations in vascular pressure, changes in liver 
metabolism and fever (3,63,74). 
Clinical disease and pathology 
Clinical signs of porcine salmonellosis may appear as septicemia or 
enterocolitis and are best illustrated using g. choleraesuis and 
S. tvohimurium infection in swine as examples, respectively. 
Salmonella choleraesuis is a highly invasive organism commonly 
causing septicemic salmonellosis in weaned pigs. Clinical signs first appear 
after 24-36 hours of infection (75). Initially pigs are restless and anorexic. 
They often have fevers of 105-107°F and may eventually die (75). 
Gross lesions induced by &. choleraesuis often include splenomegaly, 
white foci on the capsule of the liver, dark colored lungs, congested 
mesenteric lymph nodes, and a hyperemic intestinal mucosa (75,103). 
IVIicroscopically, the gastric mucosa may be congested and infiltrated with 
macrophages and neutrophils along with vascular lesions associated with 
septicemia (75). 
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Porcine salmonellosis resulting in primarily diarrhea is usually caused 
by S- tvDhimurium or other non-host adapted Salmonella. The disease may 
be acute or chronic and occurs from weaning to four months of age (103). 
The initial clinical sign is a watery, yellow diarrhea at 24 hours post­
infection, after which the infection may persist from 3-7 days. The feces 
eventually contains blood, necrotic mucosa, and mucus. Pigs may be febrile 
and dehydrated (25,75). 
Gross lesions may include a flaccid and dilated intestine, fibrinous to 
ulcerative colitis, enlarged and edematous ileocecal lymph nodes, and a 
congested and hemorrhagic ileum (75,103). Microscopically, the small 
intestinal mucosa is congested and infiltrated by neutrophils in the lamina 
propria and lymphoid follicles. The villi of the ileum may be flattened and 
covered with bacteria, mucus, and neutrophils. The colon may be intensely 
inflamed due to congestion of small vessels and infiltration of neutrophils 
and macrophages in the lamina propria (75). 
Virulence mechanisms 
Pathogens are microorganisms that have the capability to cause 
disease. The degree of pathogenicity or likelihood of causing disease is 
defined as virulence (77). Salmonella virulence is not dictated by a single 
phenotype, but rather several which work in combination to promote disease 
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(30). The virulence mechanisms to be discussed will be the 
lipopolysaccharide, bacterial association and attachment to intestinal 
epithelium, invasion, toxicity, and resistance to intracellular killing. 
Lipopolysaccharide. The cell wall of Salmonella as well as that of 
other gram-negative bacteria consists of an inner membrane, peptidoglycan 
layer, periplasmtc space and an outer membrane (40). These membrane 
components are involved in maintaining cell structure, nutrient transport, and 
protection from the external environment. One of the most important 
components of the cell wall is the outer membrane. The outer membrane is 
in direct contact with the external environment and its integrity must be 
maintained in order for the bacteria to survive (40). Associated with the 
outer membrane are flagella, pill, outer membrane proteins (OMP), and 
lipopolysaccharide (LPS) (40). 
The LPS can be divided into three main regions, the inner core 
consisting of lipid A, the middle consisting of 3-deoxy-D-manno-2-
octulosonic acid (KDO), and the outer most oligosaccharide side chains (O 
antigens) (40). The presence of 0 antigens on bacteria allows them to be 
characterized as "smooth", whereas isolates missing the 0 side chains are 
classified as "rough" (40). The LPS is considered a virulence mechanism 
because of its importance in invasion, resistance to serum components, and 
protection from cellular killing (40). Lipopolysaccharide in association with 
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membrane proteins is referred to as endotoxin, whicti has many biological 
effects on the host (discussed later)(40). Salmonella which have a smooth 
LPS are more resistant to neutrophil and macrophage killing than are rough 
isolates (40). It was shown that the LPS core was essential for resistance 
to the granules associated with phagocytic cells and the presence of 0-side 
chains helped protect from phagocyte ingestion as well as enhanced this 
resistance to intracellular killing (21,22,100). 
Adhesion. The first important step in the pathogenesis of 
salmonellosis is association with the intestinal epithelium, especially the 
ileum. The presence of flagella and adhesins are important at this stage in 
the infection. Type 1 fimbriae (mannose-sensitive) and mannose-resistant 
adhesins appear to be involved in attachment and invasion, but their role as 
a virulence determinants remains uncertain (15). Mannose-resistant 
attachment has been shown to be a prerequisite for invasion (41). 
Attachment may occur in a stepwise fashion. First, a reversible attachment 
as a result of ionic attraction occurs, followed by irreversible pili-mediated 
attachment (42). The role of type 1 fimbriae (mannose-sensitive 
hemagglutinins) in irreversible attachment has been documented, but only 
mannose-resistant hemagglutinins have been shown to facilitate 
internalization of bacteria (32,41). Flagella enhance association with the 
intestinal epithelium, but their role as a virulence determinant is also 
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important in allowing survival inside macrophages (5,99). Research 
examining animal isolates of S. tvphimurium demonstrated that 98% 
possessed type 1 fimbriae and all had flagella (58). 
Invasion. Invasion is an absolute requirement for the pathogenesis of 
salmonellosis (34). The ability of the bacteria to invade is encoded by a 
serotype-specific plasmid (34). These large virulence plasmids range in size 
from 50 kb in S. choleraesuis to 100 kb in 5. tvphimurium (31,45). 
Removal of these plasmids results in an isolate unable to invade through the 
Payer's patches (31). The plasmid had no effect on ingestion or killing by 
murine macrophages, LPS production, or serum resistance (31). There are 
conserved regions in the virulence plasmid between different Salmonella 
serovars, suggestion a common role in promoting invasion (94). 
Toxicity. The ability of Salmonella to cause diarrhea may in part be 
caused by inflammation mediated by complement and inflammatory 
substances derived from phagocytes and platelets, such as prostaglandins. 
Another reported cause of diarrhea is the £• tvphimurium heat-labile 
enterotoxin similar to cholera toxin or the £. caii heat-labile toxin (25,30). 
One study determined that 90% of the S- tvphimurium animal isolates tested 
positive for the presence of this toxin (58). Salmonella tvphimurium has a 
cytotoxin associated with the outer membrane which inhibits eukaryotic 
protein synthesis which may explain the cytopathic effects associated with 
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gastroenteritis (15,47,76). The lipid A component of LPS is the toxic 
portion of the molecule. Lipid A has been shown to activate macrophages, 
stimulate pyrogenicity, leukocytosis, cause release of pharmacologic agents 
and shock due to severe vascular changes (15,74). 
Intracellular survival. Following intestinal invasion. Salmonella must 
survive the host immune system, including complement and phagocytic 
killing (30). Phagocytes compose the first line of cellular defense 
mechanisms against invading salmonellae. The phagocytic response requires 
directed migration of phagocytes, attachment and ingestion of the 
salmonellae, stimulation of the oxidative burst, phagosome-lysosome fusion, 
and removal of bacterial debris (84,87). Neutrophils compose 30-50% of 
the porcine white blood cell population. These cells are short-lived and have 
limited metabolic activity (11). Despite this, they arrive at sites of infection 
in large numbers and are capable of killing most invading bacteria via 
oxidative and non-oxidative mechanisms (87). Monocytes compose only 3-
5% of the peripheral porcine white blood cells, have more complex 
metabolic activities, and a longer life span. Monocytes also have 
bactericidal activities within tissues, but more importantly are responsible for 
antigen processing and interaction with lymphocytes to induce humoral and 
cellular immunity (87). There is extensive evidence to indicate that although 
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these cell types do kill large numbers of invading bacteria, virulent 
Salmonella resist killing by phagocytes (39,48,73,79). 
The oxygen-independent killing is mediated by phagocytic granules 
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which contain a variety of hydrolytic enzymes and bactericidal compounds 
(84). Extracts of both subpopulations of azurophilic granules (primary) and 
the specific granules (secondary) were examined for bactericidal activity 
against S. tvohimurium (88). Bactericidal activity of the extracts was the 
most potent with a mixed population of azurophilic and specific granules, 
followed by azurophilic only, and finally specific granules only (88). 
The ability of Salmonella to resist phagocytic killing has been well 
established, but the mechanism of resistance is not certain and may vary 
with the isolate and serotype involved. Human neutrophils were evaluated 
in the presence of virulent and avirulent &. tvohi (48). Ingestion was 
equivalent for both strains. The virulent strain caused a significant decrease 
in oxygen metabolism by neutrophils, and reduced oxygen-dependent killing 
(48). The role of flagella as a virulence factor and its interaction with 
phagocytes has recently been investigated using S- tvohimurium in mice. 
Flagellated bacteria were shown to be more resistant than non-flagellated 
strains to macrophage killing in the liver and spleen. It appears that flagella 
either protect the Salmonella from intracellular killing or enhance their ability 
to multiply intracellularly (5,99). 
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Although mechanisms of bactericidal resistance have been extensively 
studied with Salmonella in humans and laboratory animals, few investigators 
have examined the interaction of S. choleraesuis with porcine phagocytes. 
Salmonella choleraesuis strains with known sensitivities to antibody-
complement lysis were examined for their resistance to porcine neutrophils 
(28). Susceptibility in vitro to the action of porcine neutrophils paralleled the 
sensitivity to antibody-complement. The strain differences appeared to be 
related to the compositions of the cell walls (27). In a second study 
comparing virulent and avirulent S. choleraesuis and their interaction with 
porcine neutrophils, it was determined that virulent S. choleraesuis were able 
to inhibit the oxidative burst, primary degranulation, alter ingestion rates, 
and therefore survive at higher rates after exposure to porcine neutrophils 
(79). 
The possible role of neutrophils in host defenses against Salmonella 
has received little attention. According to Jubb and Kennedy in Pathology of 
Domestic Animals (43): 
" the cellular defense against (Salmonella) is conducted by fixed and 
sessile phagocytes of the reticuloendothelial system and the 
polymorphs have little or nothing to do with (defense)". 
In contrast, Baskerville et al. (2) demonstrated that neutrophils had the 
ability to kill some S- choleraesuis and may actually promote the spread of 
virulent strains resistant to killing. 
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PRINCIPLES OF IMMUNITY AGAINST SALMONELLA 
Despite the extensive amount of research conducted on immunity 
against Salmonella, our understanding of the subject is still incomplete, and 
in many cases controversial. The mouse model has been used to investigate 
the basic mechanisms of Salmonella immunity and evaluate potential 
vaccines for efficacy and safety. Using the mouse model to study 
salmonellosis, two divergent views of immunity have emerged. Some 
individuals view Salmonella as a facultative intracellular pathogen requiring a 
cell mediated immunity to provide "immune elimination" of the infecting 
organism (13). This generally requires a living vaccine to induce a protective 
cell mediated immune (CMI) response. The other view claims that killed or 
cellular extracts induce a humoral response which can protect a host from 
subsequent challenge (13). 
The immune system functions through a series of complex cellular and 
humoral interactions in response to an invading foreign agent, and has been 
thoroughly reviewed (84,87). The goal of the immune system is to identify, 
control, and eliminate the agent and maintain the health of the host. The 
immune system can be divided into four basic components, all of which may 
interact to control salmonellosis. 
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Native immunity 
The native defense mechanisms include the complement system, 
phagocytes, and the physical, chemical and microbial barriers at body 
surfaces. Complement is a complex system which functions in bacterial cell 
lysis, opsonization, chemotaxis, interaction with the fibrinolysis and 
coagulation systems and consequent inflammatory process. Phagocytic 
cells are involved in ingestion and degradation of foreign debris and non­
specific protection to the host (26,87). Unfortunately, as previously 
discussed, the native defense system alone is relatively ineffective in 
protecting animals from virulent Salmonella. 
Humoral immunity 
The humoral response relies on the production of antibody by B 
lymphocytes. Antibodies contribute to protection of animals in a variety of 
ways. These include: opsonization of infectious agents which promotes 
phagocytosis, neutralization of toxins, blocking bacterial attachment, 
complement activation, and mediating attachment to cytotoxic cells 
(antibody-dependent cell-mediated cytotoxicity) (84,87). 
Induction of an antibody response against Salmonella can be 
accomplished with killed cells or cellular fractions. A variety of killed cell 
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preparations as well as purified LPS (40), proteins (20,85,96), and ribosomal 
extracts (12) have all been shown to induce a humoral immune response. 
Support for the importance of humoral immunity in protection against 
Salmonella includes increased host survival following challenge, increased 
duration of survival, and some evidence for passive protection against 
homologous strain challenge (13). However, when directly compared to 
living vaccines, they are consistently found to provide inferior protection 
(9,13). Many of the animals which survive challenge have rapid clearance of 
the organism from the blood, but some salmonellae are able to persist and 
replicate in peripheral organs (13). This may indicate that the humoral 
response eliminates enough of the challenge organism to slow death, but 
will not provide "immune elimination" or total removal/prevention of 
Salmonella infection (9). 
Cell-mediated immunity 
Cell-mediated immunity (CMI) is a complex interaction of white blood 
cells and humoral factors, all controlled by T lymphocytes. Since Salmonella 
is a facultative intracellular pathogen, it can evade antibody in the 
intracellular environment (87). Therefore a cellular response may be 
essential for the elimination of Salmonella. 
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Following animal infection, foreign agents are recognized and ingested 
by host macrophages. Macrophages have the ability to eliminate infectious 
agents by oxidative and non-oxidative killing mechanisms (87). 
Macrophages can also process antigens and express them on their cell 
surface in association with major histocompatibility complex antigens (MHC) 
(87). In addition, macrophages produce and secrete monokines which 
stimulate other macrophages and lymphocytes (84,87). T lymphocytes 
interact with antigens in association with the MHC. The T lymphocytes are 
then capable of producing and secreting humoral factors called lymphokines 
which interact with other cells of the immune system, and stimulating 
antibody production by B lymphocytes (84,87). 
In general, induction of a cellular immune response is done with a live 
organism. Many different sources of live vaccine strains have been 
examined including avirulent field isolates and attenuated isolates with 
specific mutations. The advantage of some of these vaccines is their 
persistence in the host which allows the induction of CMI as well as their 
expression of antigens stimulated by the host environment (discussed later) 
(9). 
Numerous investigators have demonstrated that live vaccines were 
superior to killed bacteria in providing increased host survival facilitated by 
"immune elimination" of the organism from organs such as the liver and 
\ 
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spleen (9,13). Live vaccines were able to induce cell-mediated immunity, 
which was associated with the removal of Salmonella from the liver and 
spleen of infected animals (9,13). There are reports of live vaccines 
providing protection against heterologous salmonellae as well as other 
intracellular pathogens (9). It was determined that induction of cell-
mediated immunity was immunologically specific, but Salmonella-specific T 
lymphocytes released lymphokines capable of stimulating non-specific 
bactericidal activity by macrophages (9,13). 
Mucosal immunity 
The fourth type of immune defense against infectious disease is the 
mucosal immune system and the production of secretory IgA. This is 
important for resistance at the mucosal surfaces such as the gastrointestinal 
tract, respiratory tract, mammary gland, and reproductive organs 
(57,60,64,95,98,104). 
IVIicrobial pathogens and toxic agents frequently make first contact 
with the host at mucosal surfaces. The animal has a variety of mechanisms 
to prevent damage or invasion at these surfaces (60). These include both 
immune and nonimmune mechanisms. The nonimmune mechanisms of host 
defense include endogenous microflora, lysozyme, lactoferrin, gastric acidity. 
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and peristalsis (60,64). The predominant immune response is the production 
of secretory IgA in the fluids that bathe the mucosal surfaces (60,64). 
The mucosal immune system acts on antigens found on mucosal 
surfaces. Antigen sampling occurs on the mucosal surface through 
specialized sites, such as the epithelium overlying the Peyer's patches. 
These epithelial cells endocytose antigen and transport it across the 
epithelial barrier (104). 
Lymphoid tissue associated with mucosal surfaces is responsible for 
induction of a mucosal immune response (104). Lymphocytes from the 
mucosal-associated lymphoid tissue migrate to submucosal sites following 
antigen stimulation. Differentiation into plasma cells occurs in the 
submucosal sites followed by antibody production. The immunoglobulin is 
produced by B lymphocytes which "home" back to mucosal surfaces, and 
IgA tends to predominate and is generally the most important in protection 
of mucosal surfaces (98). The antibody produced by B lymphocytes 
associated with mucosal surfaces is dimeric IgA and can cross the epithelial 
barrier (98). 
Stimulation of secretory IgA production generally requires the antigen 
to be delivered to the mucosal surface (64). Approaches which have been 
successful include oral inoculation, aerosolization and inhalation, and 
intramammary exposure (64). Secretory IgA protects from infectious 
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disease by preventing bacterial attachment, viral neutralization, antibody-
dependent cell mediated cytotoxicity, toxin neutralization and immune 
exclusion of soluble antigens (64). 
Variables associated with immunization 
Vaccination trials performed by different investigators are extremely 
difficult to compare due to the number of variables which alter the immune 
response and its effectiveness. Some of the factors which must be 
considered include: the source of the antigen, preparation of the antigen, 
form of antigen (soluble, adjuvants, ect.), route of inoculation (intraperitoneal 
(IP), intravenous (IV), Intramuscular (IM), subcutaneous (SC), or oral), 
dosage, number of exposures, time of challenge after vaccination, virulence 
of isolate, genetic resistance of the animal, condition of the animal, and 
environmental stress (24,44,87,105). The type of immunity produced will 
determine its effectiveness against the infectious agent. 
A soluble antigen delivered in saline may Induce a humoral immune 
response. In contrast, the same antigen administered with an adjuvant may 
induce both a humoral and cellular response. An antigen given orally may 
Interact with the GALT and possibly stimulate secretory IgA. The same 
antigen injected IV will induce little secretory antibody, but will induce a 
humoral response (IgG and IgM). 
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All of these factors must be considered when attempting to immunize 
an animal. Although there is some controversy over the relative importance 
of cellular and humoral immunity against salmonellosis, it is likely that both 
are important. In a naturally occurring infection via the oral route, live 
salmonellae would need to attach and invade the gut prior to dissemination 
to internal organs. It is thought that a secretory immune response would 
prevent bacterial attachment and invasion. Native defense mechanisms 
such as complement and phagocytes would prevent infection by low 
numbers of avirulent salmonellae. Humoral immunity would allow the rapid 
clearance of invading organisms, followed by immune elimination by a 
cellular immune response. 
27 
VACCINATION AND IMMUNITY AGAINST SALMONELLA 
Vaccination is intended to induce an immune response tliat will 
provide resistance to a specific infectious agent. In principle, vaccination 
should be administered in the same manner as the natural infection and 
should induce a similar type of immune response (44,64). 
Immunization with purified cell components 
There have been numerous attempts to immunize against Salmonella 
using purified cell components. These include outer membrane proteins 
(20,85,96,97), porins (85), ribosomes (13), and LPS or 0 somatic antigens 
(40). With the exception of ribosomes, all of these substances are 
expressed on the surface of the bacteria and are in direct contact with 
serum components and cells of the immune system. All of these substances 
have been reported to induce an active humoral immune response, which 
subsequently allows quick clearance of the organism from the blood, slows 
infection, and allows increased survival of the host (13,20,51,85,96,97). 
Some outer membrane protein preparations have been reported to also 
Induce a cell-mediated immune response (97). 
Of these purified antigens, LPS which is also found in both killed and 
live vaccines may be the most important immunogen. No investigator has 
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conclusively demonstrated protection to Salmonella without also detecting 
antibody titers to LPS. Investigators have attempted to isolate samples free 
of LPS by a variety of techniques and then used these samples to immunize 
animals (12). Despite attempts to eliminate LPS, investigators have 
continually found antibody titers against the O antigens in the sera of 
animals immunized with antigens. The very small amounts of contaminating 
LPS can not directly be detected, yet can induce protective antibody levels 
against salmonellosis in mice (12). This is consistent with the use of 0 
antigens alone as a vaccine. 
Antibody will protect against Salmonella challenge of the homologous 
O antigen type (9). The O antigens do not induce complete immune removal 
of all challenge bacteria and may allow persistent infection eventually leading 
to death (9). In some cases these purified vaccines proved to be toxic to 
the host due to the presence of LPS (9,72). 
Killed Vaccines 
A more direct immunization approach is to use killed bacterial cells or 
bacterins, which contain a variety of antigens to induce protection. Bacterial 
cells have been killed by a variety of physical and chemical means such as 
formalization, ethyl alcohol, and heating (8,9,13). 
29 
Following vaccination, these preparations have also been reported to 
induce rapid clearance, slow the rate of infection, and allow increased 
survival compared to a non-vaccinated host (13). Unfortunately, neither 
killed bacterins nor purified cell extracts induce "immune elimination" of 
Salmonella from peripheral organs of mice, something some live vaccines 
have been reported to do (9,13). 
These killed vaccines have been reported to allow 100% survival of 
mice against challenge from the homologous live challenge strain at specific 
doses. Some investigators report that killed vaccines protect by induction of 
a humoral immune response which reduces the initial challenge, prevents 
extensive multiplication, and allows cellular Immunity to develop following 
challenge. Despite these results, direct comparisons of live versus killed 
vaccines have consistently shown live vaccines to provide superior 
protection and survival at Increased levels of challenge (35). 
Currently there two bacterins commercially available for vaccination 
against salmonellosis in swine. Salmo Shield 2 (Grand Laboratories, Inc., 
Freeman, SD) contains killed S- tvohimurium and S. choleraesuis and is 
recommended for the prevention of salmonellosis. Salmo Shield C (Grand 
Laboratories, Inc., Freeman, SD) contains only S. choleraesuis and is 
recommended for protection against septic as well as respiratory 
salmonellosis (72). 
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Killed bacterins or purified bacterial components have several 
advantages compared to live vaccines. They are safe, will not produce 
disease in immuriosuppressed animals, they can't revert to virulence, and 
they are more stable. Disadvantages include an increased risk of 
hypersensitivity, limited efficacy, requirement for multiple doses, they often 
require adjuvants, they are poor inducers of CMI and mucosal immunity, and 
there is usually no immune elimination of Salmonella possibly allowing 
establishment of carrier animals (13,44). 
Attenuated Live Vaccines 
Many of the problems associated with killed vaccines can be 
overcome through the use of live attenuated vaccines. These live vaccines 
are capable of persisting in the host and have the advantage of stimulating 
an active cellular immune response. Caution must be exercised in the use of 
live vaccines due to the possibility of virulence reversion, spread of the 
vaccine organism, and the possibility of inducing disease in 
immunocompromised animals (24,105). Several different approaches have 
been attempted in live vaccine production. These will be discussed and their 
effectiveness in mice and domestic animals addressed. 
A reduced virulence field isolate recovered from pigs was found to be 
attenuated in mice and pigs and evaluated as a potential vaccine. Results 
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found the vaccine to be safe, induced a humoral and CM! response, and was 
protective when compared to non-vaccinated controls. Unfortunately the 
challenge organism was recovered from the internal organs of vaccinated 
animals and was not consistently protective (49). 
The importance of an immune response against the O antigens of 
Salmonella has been demonstrated with killed vaccines. In humans, a live S-
typhi vaccine has been developed which has a galE mutation (55). This mutant 
is deficient in UDP-glucose-4-epimerase, an enzyme which converts UDP-
glucose to UDP-galactose, an essential component of Salmonella smooth LPS. 
These gglE mutants therefore have rough LPS. The S. typhi galE vaccine has 
been used in several large trials, each using a different vaccination procedure. 
The success of this vaccine has varied between trials, but in some cases 
appeared to be very successful (55). 
The galE mutation has been used in §. typhi (O group A), S. dublin. (O 
group D) and §. typhimurium (O group B) (66). In each case there has been a 
significant reduction of virulence in mice compared to the wild-type parent as 
well as induction of protective immunity. These appear to have effective vaccine 
potential and galE mutations are being employed in many Salmonella. 
Depending on the location of the mutation in each specific bacterial clone, there 
can be a problem with stability and reversion to virulence (66). 
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Salmonella tvphimurlum and choleraesuis have O antigens types (0-
1,4,5,12) and (0-6,7), respectively. The LPS 0 antigens are the main 
difference between the two Salmonella sq. (68). The 0 antigens confer 
specificity to the Salmonella sfi., allow survival in the gastrointestinal tract, 
and entry into deeper tissues (66). Unfortunately for the swine producer, S-
choleraesuis (O group C,) with the aalE mutation did not have reduced 
virulence. This is because there is no galactose in the oligosaccharide 
repeating unit of the 0 antigen side chain. The mutation therefore has no 
effect on the virulence of this serotype (67). 
The importance of the 0 antigen in inducing a protective immune 
response led to another approach which allowed complete LPS expression. 
This approach involved the production of auxotrophic strains with defects in 
the pathway for synthesis of aromatic molecules (78). This biosynthetic 
defect caused a requirement for the aromatic compounds p-aminobenzoate 
and 2,3-dihydroxybenzoate necessary for DNA replication and enterochelin 
production. These two compounds are not available in mammalian tissues 
and therefore limit the growth and persistence of the organism in vivo (78). 
An aromatic-dependent S* tvohimurium vaccine was used in mice and 
calves, and found to be effective following both IM and oral vaccination. 
The trial contained small numbers of animals, but vaccinated animals did not 
develop diarrhea, had consistently lower fevers, appeared normal upon 
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autopsy, and had lower recovery of the challenge organism from fecal 
samples (36,78,89). This vaccine induced both a cellular and humoral 
response in calves (56). 
Other auxotrophic mutants include purine-dependent mutants of S. 
tvphimurium and S. dublin. These mutants require supplemental purines and 
have a limited life-span in the host. The isolates examined were attenuated 
in mice, but were ineffective in protecting from virulent challenge (59,70). 
A S. tvphimurium mutant (Acva/Acro) which lacks adenylate cyclase and 
cyclic AMP receptors, has provided protective immunity in mice and pigs 
following challenge with the parent organism, but allowed some recovery of 
challenge organisms from internal organs when tested in pigs (7,10,90,91). 
Failure of S- choleraesuis live vaccines to induce protective immunity 
apparently is due to their preference for an intracellular environment. The O 
antigen of S- choleraesuis has been shown to fix complement at higher rates 
than the 0 antigens from S. tvphimurium and therefore facilitates enhanced 
phagocytosis (69). Many of the ingested bacteria are killed and don't 
participate in eliciting a protective immune response. Those that do survive, 
are protected by their intracellular location in the host cells (46,65,68,69). 
There is some evidence to indicate that S. choleraesuis can be isolated from 
the neutrophils of clinically healthy pigs and may play a role in persistent 
carrier animals (81). 
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The genetics of the animal also make a significant contribution to the 
resistance of a host to Salmonella infection. Mouse studies were conducted 
with aromatic-dependent S- tvphimurium using both LPS hypersensitive 
(C3H/HeJ) and resistant (C3H/HefMCrlBR) strains of mice (46,93). 
Vaccinated mice had high levels of long-lasting protection to challenge by 
Salmonella as well as cross-protection to Listeria due to activation of non­
specific aspects of cellular immunity controlled by immune T cells (46). 
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ENVIRONMENTALLY INDUCED ANTIGENS 
AND THEIR ROLE IN VACCINATION 
Although significant advances have been made in developing 
attenuated S- tvphimurium vaccines, difficulties in vaccination against S-
choleraesuis exist mainly because of their preference for an intracellular 
environment which protects them from the immune response. Recent 
research has identified S. choleraesuis antigens expressed when the 
organism is growing in the presence of epithelial and phagocytic cells 
(17,18,92). The final part of this discussion will address the significance of 
these antigens and their possible role in vaccination. 
The ability to adhere to and invade epithelial cells is a prerequisite for 
Salmonella pathogenesis. It was recently suggested that during this invasion 
process, §. choleraesuis and S. tvphimurium required de novo protein 
synthesis (18). Although controversy exist of the exact stimuli required for 
induction, it was determined that a 40 kOa protein produced by 
choleraesuis was involved in invasion of MCDK monolayers (18). A 
transposon mutant unable to produce the 40 kOa protein was generated and 
found to be non-invasive and avirulent compared to the parent strain (18). 
This report indicated that epithelial cell exposure induced de novo protein 
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expression, some of wliich were involved in cell invasion and virulence (18). 
Other investigators also found the protein to be involved in cellular invasion, 
but no evidence for induction by epithelial exposure (52,80). 
The effect of bacterial growth stages and oxygen levels on Salmonella 
invasion was also examined. Bacteria in stationary growth phase were 
found to be non-Invasive. Bacteria grown under conditions of limited oxygen 
tended to have increased adherence and invasion capabilities (52), but were 
not statistically evaluated. It has been suggested that oxygen-limited 
environments and changes in osmolarity may induce expression of invasion 
proteins (52). This investigation also reported that the 40 kDa outer 
membrane protein was induced during logarithmic growth in culture 
contradicting the earlier investigation (52). 
It has long been thought that resistance to phagocytic killing and 
Salmonella virulence were linked, but recently the mechanism of regulation 
of this resistance has begun to be defined. Phagocytes use both oxygen 
independent and dependent mechanisms to kill bacteria (14,38,83). 
Coordinate regulation in response to environmental stimuli such as exposure 
to phagocytes, allows Salmonella to adapt to both oxygen dependent and 
independent killing mechanisms using the oxvR and phoP genetic loci 
(17,33). 
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In an attempt to define genes associated with macrophage resistance, 
investigators have made a g. tvphimurium library containing transposon 
insertional mutants (17). Phagocyte-sensitive mutants were selected which 
had the highest susceptibility (LD5o>10®) to clearance by the mouse immune 
system. These mutants were cleared from the mouse within 72 hours and 
did not induce a protection immune response against subsequent challenge 
(17). Crude granule extracts from human neutrophils were microbicidal to 
these isolates and the bactericidal activity was associated with a group of 
proteins classified as defensins (17). Defensins comprise more than 5% of 
the total protein of neutrophil granules. These small molecular weight 
cationic peptides have antibacterial, antiviral, antifungal, and cytotoxic 
activities (53). The selected mutants were 100-1000 fold more sensitive 
than the wild-type strain to killing by defensins. This mutation was 
apparently defensin-specific since cathepsin G and lysozyme sensitivity was 
the same for all isolates (17). 
Genetic analysis of the mutants indicated they contained only one 
transposon insertion, and each was located in the gene encoding for 
production of non-specific acid phosphatase (ohoP). Mutants which lack 
this gene were avirulent indicating it may regulate the expression of other 
genes involved in virulence, and response to environmental stimuli (17). 
: 
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Several Investigators have examined the role of non-specific acid 
phosphatase and its role in phagocyte resistance. Their results indicated 
that phagocyte exposure induced a 10 fold increase In ohoP activated genes, 
and Increased expression of 30-40 proteins. Two of these proteins, GroEL 
(58 kDa) and DnaK (68 kDa) originally identified as heat shock proteins (4) 
were immunodominant and essential for survival of Salmonella in phagocytes 
(4,17). They conclude that surviving intracellular bacteria produce large 
amounts of these two proteins which are processed and then presented on 
the surface of the macrophage (4). It is these induced proteins which are 
not expressed In killed bacterins which may be necessary for effective 
vaccination against in vivo salmonellosis (4), It was also determined that 
regulation of non-specific acid phosphatase production was required for 
maximum virulence, since over production led to an attenuated isolate 
(23,29,61,62). 
The other bactericidal mechanism employed by phagocytes Is the 
production of toxic oxygen products such as hydrogen peroxide, superoxide 
anion, singlet oxygen, and hydroxy I radicals. These can oxidize fatty acids, 
proteins, and damage DNA (33). Enteric bacteria have several enzymes that 
help protect from oxidative damage such as superoxide dismutase and 
catalase (33). 
I 
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Salmonella tvphlmurium exposed to hydrogen peroxide was able to 
adapt and become increasingly resistant to previously toxic levels (6). 
During this adaptation process several changes occurred in the bacterial 
phenotype. These include: induction of 30 proteins, increased production of 
catalase, super oxide dismutase, glutathione reductase, and alkyi hydrogen 
peroxide reductase (6). A mutant which was resistant to hydrogen peroxide 
was isolated and found to constitutively express at least three heat shock 
proteins (6). This mutation was found to be in the oxvR gene. This gene 
regulates defense against oxidative stress and is part of a global regulatory 
system found in many enteric bacteria (6). It was determined that the oxvR 
gene is needed for resistance to hydrogen peroxide exposure and the heat 
shock response (6). 
Exposure to phagocytic cells can change the virulence of Salmonella. 
Salmonella choleraesuis repeatedly exposed to neutrophils led to a neutrophil 
adapted strain which was avirulent and immunogenic for mice and pigs. 
Characterization of the isolate indicated loss of the 50 kb virulence plasmid 
necessary for invasion, had increased resistance to oxygen radicals and 
phagocyte killing, and increased expression of outer membrane proteins 
(81,82). Controlled experimentation with the isolate in pigs has allowed 
continued weight gain, shown it to be safe and protective following 
challenge with different strains of virulent choleraesuis (50). The nature 
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of the immune response produced by this isolate has not been characterized 
to date, but the isolate is currently being used in vaccine trials and 
preliminary data appear promising (50). 
After years of research on immunization against salmonellosis, 
advances have been made, but the problem is still not solved. It appears 
that an orally administered live vaccine which stimulates cellular, humoral, 
and secretory immunity may provide the most complete protection. Current 
work with S. tvohimurium appears close to meeting these needs, but 
immunity against S- choleraesuis-is still undefined. It may be necessary to 
consider the environmental stimuli that g. choleraesuis are exposed to and 
further define coordinately regulated antigens expressed under in vivo 
conditions. Bacteria grown in vitro may be missing key antigens that are 
expressed in vivo. Identification of coordinately regulated antigens may 
allow immunization with these in purified forms, or cloned in expression 
vectors allowing safe and effective vaccination against salmonellosis. 
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ABSTRACT 
Salmonella choleraesuls strain 38 (glycerol positive fermentation) was 
repeatedly exposed to porcine neutrophils in an attempt to mimic in vivo 
conditions of the host immune system. After phagocytosis, viable 
intracellular &. choleraesuls were isolated and the process repeated at least 
five times. After the fifth passage strain 38 neutrophil-adapted clone, 
38PMNa-5X, was isolated and then examined for changes compared to the 
parent wild type strain 38. Strain 38PMNa-5X had increased resistance to 
killing by hydrogen peroxide and phagocyte killing by porcine neutrophils as 
measured by 3-I4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
reduction. Strain 38PMNa-5X was significantly less invasive than the parent 
strain on Vero cell monolayers, and had been cured of a 50 kb plasmid. The 
50 kb plasmid was marked with mini-Mu (Km') and re-inserted into 
strain 38PMNa-5X. The resultant kanamycin resistant isolates were 
intermediate in resistance to neutrophil and hydrogen peroxide killing, but 
had restored invasiveness. No differences were noted between the strains 
in complement sensitivity and enzymatic activity. 
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INTRODUCTION 
Salmonella choleraesuis is a facultative intracellular pathogen causing 
swine paratyphoid, a septicemic disease of pigs (28). Pigs become infected 
by ingestion of contaminated food at which time S- choleraesuis invades the 
intestinal epithelium. The bacteria are then exposed to local phagocytic 
cells, including macrophages and neutrophils. The bacteria may eventually 
enter the blood and be disseminated to various organs (17,27). Some 
Salmonella resist killing by phagocytic cells using a variety of mechanisms, 
such as inhibition of the oxidative response, inhibition of phagosome-
lysosome fusion, resistance to oxidative and non-oxidative killing, presence 
of flagella, and lipopolysaccharide (13,14,16,19,23,25,26). 
The interaction of Salmonella with phagocytes may also induce 
bacterial changes. Salmonella tvphimurium has been shown to induce over 
30 proteins upon interaction with macrophages (3). Two of these proteins 
are the immunodominant heat shock proteins GroEL and DnaK which appear 
to contribute to bacterial survival (2). Heat shock proteins have also been 
induced by hydrogen peroxide which mimics conditions of oxidative killing 
by phagocytes. Mutants unable to produce these proteins were 
hypersensitive to killing by hydrogen peroxide and neutrophils (3,23). 
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Two systems of inducible genes in Salmonella have been described 
which relate to intracellular phagocyte survival. The oxvR gene regulates 
genes induced by oxidative stress in &. tvphimurlum and Escherichia coli 
(24). Hydrogen peroxide exposure has been shown to induce as many as 30 
proteins (3). Mutants over-expressing these genes were more resistant to 
killing than were the wild-type parent (3). The ohoP/phoQ genes control the 
expression of essential proteins for S. tyohimurium virulence and survival in 
macrophages (18). Mutants which constitutively express ohoP had changes 
in at least 40 proteins and were attenuated for virulence and survival in 
macrophages (1). 
Macrophages that help protect against invasion through the intestinal 
epithelium have an extended life-span and are capable of continued 
metabolic activity. Macrophages circulate one to three days and then live in 
the tissues for 4-12 wks (4). In contrast, the neutrophil has a half-life of 
only 6-8 h in the blood and is found extravascularly for only seven hours to 
four days (4). Therefore, S. choleraesuis may be maintained inside a 
monocyte for an extended period of time, or may outlive neutrophils and be 
repeatedly ingested and exposed to phagocyte bactericidal mechanisms. 
The purpose of this investigation was to determine the changes 
associated with Salmonella virulence following exposure to porcine 
neutrophils. Strain 38 was used in this investigation because of its 
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virulence, and ability to ferment glycerol ( + ) which was used as a marker 
for recovery. This has been evaluated by measuring virulence in a mouse 
model, resistance to phagocyte killing, plasmid analysis and invasion. 
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MATERIALS AND METHODS 
Bacterial strains and cultures 
Bacterial isolates were grown on MacConkey agar (Difco Laboratories, 
Detroit, Mich.) and pure cultures isolated. Cultures were stored on 
trypticase soy agar (TSA) (Difco) soft agar slants at room temperature, and 
in trypticase soy broth (TSB) (Difco) containing 15% glycerol at -70°C. 
Routine growth of bacterial isolates was performed on TSA at 37°C for 12 
h. Bacterial strains E. eoN MCI040-2 and LE392 were propagated in Luria 
broth (21) or in some cases super broth (32 g tryptone, 20 g yeast extract, 
5 g sodium chloride per liter). Descriptions of genotypes are presented in 
Table 1. 
Cell culture 
Vero cells were obtained from the National Veterinary Services 
Laboratory U.S.D.A.. Vero cells were grown in Dulbecco's minimum 
essential media (DMEM) (Sigma Chemical Co., St. Louis, Mo.) with 10% 
fetal calf serum (Hyclone Lab.Inc., Logan, Utah), at 37°C with 5% CO;. 
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Neutrophil isolation 
Porcine neutrophils were obtained from freshly collected, 
anticoagulated blood from normal pigs. Neutrophils were isolated using a 
Percoll gradient procedure as previously described (19). 
Neutrophil passage of g. choleraesuis 
An overnight culture of S. choleraesuis 38 grown on Maconkey agar 
was exposed to isolated porcine neutrophils in a bactericidal assay as 
previously described (19). Opsonized S. choleraesuis were incubated in 
Ml99 (Sigma) with neutrophils for 30 min to allow ingestion. Gentamicin 
(100//g/ml) and kanamycin (100//g/ml) were added for one h to kill all 
extracellular bacteria. The neutrophils were allowed to settle and the 
supernatant was sampled to insure killing of extracellular Salmonella. A 
separate sample of choleraesuis without neutrophils was also exposed to 
antibiotics to measure killing. The neutrophils were washed three times with 
phosphate buffered saline (PBS; 0.15 M NaCI in 0.015 M phosphate buffer, 
pH 7.4), and resuspended to their initial volume. A 100 //I aliquot was 
removed and lysed with distilled water to release intracellular bacteria. This 
sample was then diluted and plated on Maconkey media and grown 
overnight at 37°C. Individual colonies were picked and resuspended to 2 X 
10® colony forming units (CFU)/ml. This procedure was repeated five times 
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to enrich for a population of neutrophil-resistant S. choleraesuis. After the 
fifth passage, a single glycerol positive ( + ) clone was selected for 
observation and designated S. choleraesuis 38PMNa-5X. A separate control 
consisting of neutrophils not exposed to Salmonella was also examined for 
the presence of contaminating intracellular bacteria. All remaining 
neutrophils isolated from the gradient were lysed and directly plated on 
Maconkey media at 37 C overnight to insure sterility. 
Mouse infection with g. choleraesuis 
Bacteria were suspended to 2 X 10® CFU/ml in PBS and tenfold 
dilutions from 10^ to 10^ CFU/ml were injected intraperitoneal (i.p.) into 
BALB/c mice as described (5). 
S. choleraesuis susceptibility to neutrophil Idlling 
The susceptibility of &. choleraesuis 38 and 38PMNa-5X to neutrophil 
killing was assessed by two methods: 1 ) A modification of a colorimetric 
assay that measured the ability of live bacteria to reduce 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to purple 
formazan was employed (22). Opsonized S. choleraesuis (2 x 10®/ml) in 
RPIVII 1640 (Sigma) with 10% PCS (Hyclone) was incubated for 1 h with 1 x 
10^ neutrophils/ml. Following incubation, 0.2% Saponin was added to lyse 
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the neutrophils. The remaining live S- choleraesuis were allowed to reduce 
MTT and then compared to a standard curve to determine the numbers of 
viable &. choleraesuis. 2) A hydrogen peroxide sensitivity test was 
performed comparing the viability of S. choleraesuis 38 and PMNa-5X after 
exposure to 60 mM hydrogen peroxide for 1 h (3). 
Determination of Salmonella invasion of Vero Cells 
The invasion assay was performed in eight well plates as previously 
described (20). Briefly, freshly prepared salmonellae (500 //I) were added to 
each well in a ratio of 1000:1 bacteria (2 x 10°) to Vero cells (2 x 10°). 
After 2 h incubation, wells were washed 3 times with DMEM containing 100 
//g/ml gentamicin to kill all extracellular bacteria. Control wells containing 
bacteria only were performed at the same time to measure the killing of 
extracellular bacteria. Wells were incubated for an additional 2 h with 
DMEM containing gentamicin. The supernatants were examined for sterility 
by plating onto brain heart infusion agar (BHI) (Difco). The wells were 
washed an additional 3 times with DMEM to remove gentamicin, and the cell 
monolayers were lysed using 0.1% sodium dodecyl sulfate, releasing all 
intracellular bacteria. Samples from each well were then diluted in PBS and 
plated in quadruplicate to determine the CPU. Results were expressed as 
the mean and standard error of the mean of five experiments. 
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Plasmid analysis 
Plasmid DNA was isolated from bacterial isolates by an alkaline lysis 
method (21) from overnight cultures grown in super broth (21) and purified 
by an ethidium bromide-cesium chloride gradient as previously described 
(21). Plasmid analysis was performed using a 0.5% agarose gel in Tris-
borate buffer (21), run for 4 h at 70 mV and stained with ethidium bromide 
(21), Southern blots were performed using nylon membranes (Schleicher & 
Schuell Inc., Keene, NH) and a standard methodology (21). The 50 kilobase 
plasmid of S. choleraesuis was excised from the gel, isolated using 
Geneclean II (Biol01 Inc., La Jolla, Cal), and labeled with ^^P-CTP using 
oligonucleotide labeling (Amersham Corp., Arlington Heights, III.). 
The introduction of the 50 kb plasmid into the cured strain 38PMNa-
5x was accomplished by labeling the plasmid from strain 38 with mini-Mu 
followed by transformation into the recipient and selection for kanamycin 
resistance (10). Lysates of mini-Mu phage were prepared by 
thermoinduction of E. ggli MCI040-2 which contained mini-Mu as a plasmid 
replicon and also Mu£ts62 temperature-sensitive helper phage in the 
chromosome (10). Infections were performed by mixing dilutions of phage 
with mid-log phase culture of strain 38. Following a 2 h incubation, cells 
were plated on TSA media containing kanamycin (10 //g/ml) containing agar. 
Resistant colonies were collected in bulk and grown overnight in super broth 
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at 37®C and the plasmid DNA prepared as described above. Plasmid DNA 
was isolated by electroelution from agarose slices using an Elutrap 
(Schleicher & Schuell) run at 200 mV for 18 h. Strain 38PMNa-5X was 
electroporated with this plasmid preparation, using a BTX 100 power supply 
(San Diego, Cal.) at 725 mV for 5 msec and an electrode gap of 0.5 mm. 
The bacteria were then plated on kanamycin agar. Plasmid DNA was 
isolated from kanamycin resistant colonies, and analyzed by DNA-DNA 
hybridization as described above. Three kanamycin resistant clones, 38-
K28, 38-K65, and 38-K71 were chosen for further analysis. Figures 1 and 2 
were prepared by the Image Analysis Facility, Iowa State University, Ames, 
la. 
Complement sensitivity 
Normal porcine and guinea pig sera were obtained by venipuncture, 
aliquoted and stored at -20°C. These sera did not agglutinate Salmonella 0 
and H antigens. The complement assay was conducted as described 
elsewhere (15). Briefly, overnight cultures of Salmonella were diluted 1:100 
in TSB and incubated at 37°C until they reached an O.D. of 0.20 at 540 nm 
(2 X 10® CFU/mi). The bacteria were then centrifuged at 5000 X g for 10 
min and resuspended in PBS. Bacteria (500 //I) were then added to 2 ml of 
PBS containing serum at concentrations ranging from 10-50%. The 
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bacterial suspensions were then incubated at 37°C and samples taken at 0 
and 90 min, diluted in PBS, and plated in triplicate on MacConkey agar for 
viable counts. 
Carbohydrate and enzymatic activity 
S. choieraesuis strain 38 and 38PMNA-5X were examined by API-CHE 
for fermentation of 49 substrates, and for 19 enzyme activities by API-ZYME 
(API Analytab Prod., Plainview, NY). 
Statistical analysis 
Data were analyzed by the Student's t test as previously described 
(29). All experiments were carried out in at least triplicate with reproducible 
results. 
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RESULTS 
g. choleraesuis virulence for mice 
Tlie parent strain 38 was virulent in Swiss-Webster and BALB/c mice 
by footpad and i.p. Injection with an LD50 of The PMN-adapted 
derivative, 38PMNa-5x had a LDgg of greater than 10® in BALB/c mice. 
Pathogenicity of Salmonella for mice was evaluated based on death, spleen 
Infection and number of recovered bacteria. The parent strain 38 caused 
100% death, 100% spleen infection, and Logio8.4 bacteria per spleen, but 
strain 38PMNa-5X failed to infect spleens or kill mice (Table 2). Strain 
38PMNa-5X had been cured of a 50 l<b plasmid, and following re-insertion of 
a kanamycin-marked plasmid, virulence was partially restored. Death rates 
of the resulting strains (38-K28, 38-K65, and 38-K71) ranged from 16-66% 
with 100% infection of spleens and bacterial recovery intermediate between 
strain 38 and 38 PIVINa-SX (Table 2). 
Viability of S. choleraesuis following PIVIN and hydrogen peroxide exposure 
The overall viability of these two isolates following neutrophil 
exposure and ingestion was determined colorimetrically by measuring the 
reduction of MTT to formazan. The parent isolate 38 remained 32% viable 
after 1 h of neutrophil exposure compared to 56% viability for the 38PMNa-
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5X isolate (Table 3). Strains 38-K28, K65, and K71 were intermediate in 
resistance to neutrophil killing (Table 3). Viability was also examined after 
exposure to hydrogen peroxide. Salmonella choleraesuis was exposed to 60 
mM hydrogen peroxide for 1 h and then viable numbers of bacteria 
determined by plating and counting CPU. The parent isolate 38 remained 
50% viable after one h compared to 65% viable for the PMN adapted 
38PMNa-5X (Table 3). Strains 38-K28, K65, and K71 were intermediate in 
susceptibility to hydrogen peroxide killing (Table 3). 
DNA analysis 
Plasmid DNA was isolated from S. choleraesuis before and after 
neutrophil passage. Following the PMN-adaptation process, the isolate was 
cured of its large virulence plasmid (Fig. 1). This was confirmed by DNA-
DNA hybridization using a ®^P-labeled virulence plasmid from the parent 
strain as a specific probe (Fig. 1). To determine the role of the virulence 
plasmid in the phenotypic changes noted following neutrophil-adaptation, 
strain 38 PMNa-5X was re-introduced with a 50 kb plasmid from the parent 
strain. This was accomplished by marking the parent plasmid with a 
derivative of the bacteriophage Mu coding for kanamycin resistance (10). 
The marked plasmid was introduced by electroporation and presence of the 
plasmid was confirmed by DNA-DNA hybridization (Fig. 2). Thirteen 
kanamycin resistant derivatives (K-strains) of strain 38Pi\/lNa-5X were 
isolated by mini-Mu transfection and placed into mice to study their 
virulence potential. Of these, three were recovered from mice after 14 d, 
38-K28, 38-K65, and 38-K71. These three strains displayed intermediate 
virulence between the parent strain and the neutrophil adapted strain 
38PMNa-5X using mortality, spleen invasion, and the number of recovered 
bacteria as the criteria for virulence (Table 2). They were recovered from 
100% of the mouse spleens in intermediate numbers, and had death rates 
ranging from 16-66% (Table 2). In these strains, the plasmid was stably 
maintained during the in vivo passage (Fig. 2). 
Invasion of Vero cell monolayers by g. choleraesuis 38 and 38PMNa-5X 
To determine the invasiveness of these isolates, confluent Vero cell 
monolayers were incubated with live S- choleraesuis as previously described. 
S. choleraesuis 38 was recovered at a rate significantly higher than 
38PMNa-5X (3.8 vs 1.1 Log,o CFU/ml) (Table 3). Strains 38-K28, 38-K65, 
and 38-K71 had their invasive capabilities restored by the re-introduction of 
the 50 kb plasmid (Table 3). 
68 
Complement sensitivity 
Both isolates were resistant to 50% fresh normal porcine and guinea 
pig sera. No difference could be noted by optical density of growth or 
recovery of CFU/ml from the serum sample. The parent strain was 95 +/-
3.0 % viable and the attenuated 38 PMNa-5X was 96 +/- 2.2% viable after 
90 min of serum exposure. 
Carbohydrate and enzymatic activity 
Carbohydrate utilization was examined by the API-CHE system for 
enteric bacteria. Forty-nine carbohydrates were examined and both strain 
38 and 38 PMNa-5X fermented the same fifteen of forty-nine samples. One 
of the fifteen carbohydrates fermented by both 38 and 38 PMNa-5X was 
glycerol. Glycerol is not typically fermented by £. choleraesuis and allowed 
differentiation from all other laboratory and field isolates examined. Strain 
38 PMNa-5X was serologically and biochemically identical to the parental 
strain 38, both have the API-20E idenfication number 4504510, and are 
distinctly different from all other isolates of S. choleraesuis examined 
(unpublished data). Examination of glycerol negative isolates found 
reversion to glycerol positive to be greater than one in 10® CFU/ml. 
Enzymatic activity was examined using the API-ZYME system with both 
isolates positive for the same 5 of 19 substrates. 
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DISCUSSION 
The pathogenesis of S. choieraesuis depends on its ability to invade 
the intestinal epithelium, survive the host immune response, and then 
disseminate in the host. The ability of Salmonella to resist phagocyte killing 
has been well documented (16,19), but only recently has the role of 
environmental induction of bacterial determinants been investigated. 
The hypothesis of this research was that during infection, g. 
choieraesuis are repeatedly exposed to ingestion and killing by host 
phagocytes. During this process, intracellular environmental stimuli from the 
phagocytes might induce genetic or phenotypic changes in the viable S. 
choieraesuis. Our goal was to mimic these conditions in vitro and identify 
changes associated with porcine neutrophil association. 
Investigations defining typical S- choieraesuis fermentation patterns 
report no (0%) glycerol fermentation (6). The standard API-CHE (API 
Analytab Prod., Plainview, NY) profile also indicates no (negative (-)) glycerol 
fermentation for S. choieraesuis. This allowed glycerol fermentation to be 
used as an identification marker and allowed confirmation that strain 38 or 
its derivative were being maintained. 
Following neutrophil exposure, isolates had increased resistance to 
killing by neutrophils as well as resistance to hydrogen peroxide. This may 
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have been due to selection for isolates which constitutively express 
resistance proteins, similar to OxyR and PhoP as described with g. 
tvphimurium (7,11,24). 
The loss of virulence in these isolates for mice was unexpected. One 
possible explanation may be the loss of the g. choleraesuis 50 kb plasmid 
previously shown to be involved in the invasion process and virulence (12). 
Our data supports this conclusion since the re-introduction and stable 
maintenance of the plasmid resulted in partial restoration of virulence (Table 
2). Because full virulence was not restored, other genetic changes may 
have also occurred in the neutrophil-adapted strain. This may correlate with 
induction of stress- or heat-shock proteins beneficial for survival inside 
neutrophils (2), but our studies did not address this possibility. Sixteen of 
19 K-strains did not maintain the virulence plasmid in-vitro and subsequently 
were not recovered from mice. This suggests that a genetic lesion(s) had 
occurred in the neutrophil-adapted strain in a gene(s) involved in plasmid 
stability. The stable K-strains (38-K28, K65, and K71) would thus contain 
revertants or suppressor mutations that support maintenance of the 
virulence plasmid. Since total virulence was not restored, other undefined 
changes also may have occurred in the neutrophil adapted strain. 
In conclusion, the following changes were noted in g. choleraesuis 
following repeated PMN exposure; 1 ) There was an overall increased 
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resistance to neutrophil killing and killing by hydrogen peroxide, 2) the 
neutrophil adapted S. choleraesuis lost the large virulence plasmid, 3) the 
virulence of the neutrophil adapted isolate (38 PMNa-5X) for mice was 
decreased, 4) S. choleraesuis 38PMNa-5X was non-invasive in a Vero cell 
assay, and 5) partial restoration of choleraesuis 38PMNa-5X virulence and 
invasiveness was obtained by re-insertion of the 50 Kb. 
TABLE 1. Bacterial strains 
Strain Description Source or reference 
38 
38PMNa-5X 
38-K28 
38-K65 
38-K71 
X3246 
MCI 040-2 
LE392 
S. choleraesuis wild type (glycerol +) 
S. choleraesuis neutrophil adapted 5 passages (glycerol +) 
S. choleraesuis 38PMNa-5X mini-Mu (Km') marked piasmid 
S. choleraesuis wild type 
E. coli F'araD169 araB::Mu cts AlacX74 oalU oalK rpsL. 
pEG5005 
E. coli F" hsdR514 (r^-.m^-) lacYI supE44 aslT22 trpRSS 
metBI 
(8,9,19,20) 
this work 
this work 
this work 
this work 
Dr. Roy Curtiss 
(10) 
F.C. Minion 
Nj N3 
TABLE 2. Virulence of S. choleraesuis 38 and 38PI\/INa-5X in BALB/c mice following intraperitoneal 
injection. 
INOCULUM # OF BACTERIA # MICE %DEATH %INFECTION LOGIXFU/SPLEEN 
38 1.8 X 10^ 6 100 100 8.4 
38PMNa-5x 2.1 X 10^ 12 0 0 0 
38-K28 2.5 xlO^ 6 66 100 4.4 
38-K65 4.5 xlO^ 6 16 100 4.1 
38-K71 3.8 X 10^ 6 50 100 4.2 
TABLE 3. Comparison of S. choleraesuis and their resistance to neutrophil l<iiling, hydrogen peroxide, and 
Vero cell invasion 
Strain MTT» VERO CELL INVASION" 
(% Survival) (% Survival) (Log,o CFU/ml) 
38 32.1 + /- 2.1" 50.5 + /-
ôq d
 3.8 + /- 0.4 
38PMNa-5X 56.2 + /- 2.9" 65.2 + /- 2.2" 1.1 + /- 0.8' 
38-K28 49.1 +/- 6.3 60.7 + /- 3.7 3.5 + /- 0.9 
38-K65 48.7 + /- 5.5 58.6 + /- 4.1 3.5 + /- 1.1 
38-K71 40.3 + /- 4.2 55.0 + /- 2.9 3.1 + /- 0.6 
(*) S. choleraesuis strains were evaluated for their resistance to neutrophil lulling after 1 h as measured by 
reduction of 3-[4,5-dimethylthiazol-2-yn-2,5-diphenY!tetrazolium bromide (MTT). 
{'') Isolate viability was examined after exposure to 60 mM hydrogen peroxide for 1 h. 
(") Vero cell invasion was determined by exposing S. choleraesuis strains to confluent Vero cell monolayers 
for 2 h, and killing of extracellular bacteria with gentamicin (100 iug/ml). Viable bacteria were recovered 
and expressed as Log^o CFU/ml. Data {' *'•'') represents mean +/- S.E.M. of five experiments. 
M-identical letters indicate significant differences (P<0.01) between strains. 
(')-this isolate is significantly different (P<0.01) than all other strains. 
75 
* 
B 
(*)-lndicates location of large virulence plasmid. 
Figure 1. Comparison of Salmonella isolates after neutrophil exposure 
by agarose electrophoresis and Southern blot hybridization. Panel 
A is an ethidium bromide stained agarose gel comparing S. 
choleraesuis before and after neutrophil exposure. Strain 
38PMNa-5X (lane a), 38 (lane b). Panel B is a Southern blot 
using the virulence plasmid from the parent isolate as a 
hybridization probe. Lanes are identical as described for Panel A. 
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A 
b c d o f  g  1 1  i j k  
B 
à b o d a f  g  h  i  J  k
Figure 2. Plasmid and Southern blot analysis of S. choleraesuis 38 
containing the 50 kb virulence plasmid (open arrow), 38PMNa-5X 
cured of the virulence plasmid, and transformants 38-K28, 38-
K65, and 38-K71 with a mini-Mu marked 50 kb plasmid (filled 
arrow). Panel A is an agarose gel stained with ethidium 
bromide. Lanes a-e are plasmid isolates prior to mouse infection. 
Strain 38PMNa-5X (lane a), 38 (lane b), and 38-K28. 38-K65, 
and 38-K71 (lanes c-e respectively). Lanes f-j are isolates 
recovered from mouse spleens following infection, and contain 
strain 38PMNa-5X, 38, 38-K28, 38-K65, and 38-K71, 
respectively. Lane k contains S. choleraesuis x3246 with a 
known 50 kb plasmid. Panel B is a Southern blot of the 
corresponding gel using the 50 kb plasmid isolated from strain 38 
as a probe. 
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SECTION 3: IN VIVO ISOLATION OF SALMONELLA CHOLERAESUIS 
FROM PORCINE NEUTROPHILS 
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ABSTRACT 
Seventy-five pigs from four different facilities were examined for the 
presence of Salmonella choleraesuis. Animals were examined for the 
presence of Salmonella by bacteriologic culture of feces, blood, white blood 
cells (buffy coat), mononuclear leukocytes, and neutrophils. 
Salmonella choleraesuis was isolated from 0/75 fecal samples compared to 
39/75 from purified neutrophil preparations. Six of the pigs did not have 
Salmonella isolated from feces or whole blood, but did have S. choleraesuis 
isolated only from purified neutrophils preparations. Six animals from two 
different groups were culture positive for &. choleraesuis usina neutrophil 
samples. These animals were examined at least three successive times to 
test for repeatability and to determine the optimum number of neutrophils 
required for Salmonella isolation. These animals were then killed and 
examined at necropsy. Nineteen samples from each animal were cultured 
and only the peripheral blood neutrophils were found to be positive for §. 
choleraesuis. These results indicate that neutrophils may contribute to the 
carrier state in pigs and should be cultured when attempting to identify S. 
choleraesuis carrier animals. 
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INTRODUCTION 
Salmonella choleraesuis belongs to serogroup C, of Salmonella, and Is 
the cause of a septicemic disease in swine known as swine paratyphoid. 
S. choleraesuis is host adapted and accounts for 95% of the Salmonella 
recovered from pigs in Iowa, and 69% nationally (1). 
The infection of animals by Salmonella normally begins after fecal-oral 
transmission. Bacteria colonize and invade the intestinal epithelium, 
disseminate to peripheral organs, and cause septicemia which may kill the 
host (5). S. choleraesuis is a facultative intracellular pathogen capable of 
resisting phagocyte killing. These resistance mechanisms include: inhibition 
of the oxidative response, inhibition of primary granule degranulation, 
inhibition of phagosome-lysosome fusion and resistance to lysosomal 
enzymes (2,6,8,10,11,16,18,19). 
It has been reported that pigs may be frequently exposed to low 
numbers of salmonellae that establish a clinically inapparent infection or 
carrier state (15,20). Following stress or concurrent disease, S. 
tvDhimurium and g. choleraesuis may cause clinical disease (15,20). 
The carrier state of Salmonella in swine has been experimentally 
studied with S. tvohimurium. Animals were found to be infected by the 
organism for up to twenty-eight weeks with 14% of these animals 
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Salmonella positive at necropsy (21). Mesenteric lymph nodes from healthy 
pigs have also been found to contain S. tvohimurium upon slaughter (7,9). 
Multiple fecal cultures must be done on each animal before salmonellae can 
be isolated (20). Antibiotic treatment does not reduce fecal shedding in 
animals with enterocolitis, but does reduce the magnitude and duration of 
shedding in animals with septic forms of the disease (20). 
The purpose of this investigation was to determine the role of 
neutrophils in the carrier state of naturally infected pigs, and to identify 
additional samples which may supplement fecal cultures to identify pigs 
which carry g. choleraesuis. This will not only allow a better understanding 
of the pathogenesis of the disease, but will also allow more accurate 
identification of animals with salmonellae, an important first step in 
eradication programs. 
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MATERIALS AND METHODS 
Bacterial strains and cultures 
Bacterial isolates were grown on MacConkey agar (Difco Laboratories, 
Detroit, Mich.) and pure cultures were isolated. Cultures were stored on 
trypticase soy agar (TSA) (Difco) soft agar slants at room temperature, and 
in trypticase soy broth (TSB) (Difco) containing 15% glycerol at -70®C. 
Routine growth of bacterial isolates was performed on TSA at 37®C for 12 
h. Salmonella choleraesuis parent strain 38 and its in vitro neutrophil 
adapted isolate, 38 PMNa-5X, have been previously characterized (13) 
Source of animals 
Pigs from four different facilities were selected based on their current 
health status, age, and history of disease attributed to salmonellosis. 
Group 1 Three healthy gilts with no past history of salmonellosis 
were housed in an isolation unit at the Veterinary Medical Research Institute, 
Iowa State University, weighed approximately 180-200 lbs., were in good 
health, and were not on any medication. 
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Group 2 Twenty-four pigs were randomly selected from a herd of 
100 animals with no history of salmonellosis. The animals were housed on 
an Iowa State University teaching farm, were 4 months old, weighed 
approximately 130 lbs, appeared healthy and were not on medication. 
Group 3 Twenty-four cross-bred pigs were randomly selected from 
a herd of 130 animals with a history of periodic salmonellosis. Pigs were 
housed on an Iowa State University research farm, were approximately 4 
months of age, weighed approximately 100 lbs, were in good health, but 
were on medication in feed 48 h prior to sampling (Carbadox). 
Group 4 Twenty-four cross-bred pigs were randomly selected from 
a herd of 500 animals with a history of periodic salmonellosis. Pigs were 
housed on a private farm, were 4-5 months of age, weighed approximately 
180 lbs, and were not on medication. 
Salmonella sampling and culture procedure 
The following samples were routinely taken from each animal when 
attempting to isolate Salmonella: feces (1-3 gm), blood (2 ml), buffy coat 
(10% of total buffy coat from 50 ml of blood), gradient purified mononuclear 
leukocytes (>100 X 10® cells), and gradient purified neutrophils (25 X 10® 
cells). Salmonella isolation and identification was performed as described 
(17,21). Briefly, samples were inoculated into 15 ml buffered peptone 
89 
(Difco, Detroit, Ml) water (17) for 12 h at 37 C. The peptone water was 
streaked directly onto MacConkey agar plates (Difco, Detroit, Ml) and 
incubated 12 h at 37 C for all samples except feces. Samples streaked onto 
MacConkey agar were examined for the presence of lactose negative 
colonies (Salmonella) after 12 and 48 h in peptone water. Following 
incubation in peptone water, fecal samples were Inoculated (1 ml) into 
Rappaport-Vassiliadis (RV) media (15 ml) overnight at 37 C and then 
streaked onto MacConkey media (17). Lactose negative colonies from all 
samples were analyzed on Kliglers' slants, SIM media, and urea slants 
(Difco, Detroit, Ml). Isolates which were consistent with Salmonella 
reactions were then confirmed by API-20E (API Analytab Prod., NY), and by 
group-specific 0 antigen agglutination. Serotypes were determined at the 
National Veterinary Services Laboratory, U.S.D.A., (Ames, Iowa) by analysis 
of 0 and H antigens. All blood samples containing leukocytes were first 
lysed with either distilled water or 0.1% saponin in PBS prior to inoculation 
into the peptone water. 
Leukocyte isolation 
Leukocytes were separated and isolated as previously described (11). 
Briefly, pigs were bled from the anterior vena cava and 50 ml of blood was 
collected into siliconized glass tubes containing 8 ml of Acid-Citrate 
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Dextrose (ACD) anti-coagulant. Blood was centrifuged for 20 min at 1500 x 
g and the buffy coat removed (5 ml). Erythrocytes in the buffy coat were 
lysed twice with phosphate buffered deionized water, and the remaining 
leukocytes resuspended in 1 ml of PBS. This leukocyte sample was used for 
bacteriologic examination of the buffy coat and the remaining cells separated 
on a stepwise (80%, 70%, and 45%) Percoll gradient. This method enabled 
the isolation of relatively pure (>95%) samples of neutrophils (interface of 
70-80% Percoll) and mononuclear cells (interface of 45-70% Percoll). Cells 
were harvested from the gradient, washed twice with PBS, and standardized 
with a cell counter to the amounts indicated above. 
Plasmid DNA isolation and analysis 
Plasmid DNA was isolated by passage of TSB grown cells across a 
Qiagen column (Qiagen, Studio City, CA). Plasmid analysis was performed 
using a 0.5% agarose gel in Tris-borate buffer (14), run for 4 h at 70 mV 
and stained with ethidium bromide (14). Southern blots were performed 
using nylon membranes (Schleicher & Schuell Inc., Keene, NH) and standard 
methodology (14). The 50 kilobase plasmid of S. choleraesuis was excised 
from the gel, isolated using Geneclean II (BiolOI Inc., La Jolla, Cal), and 
labeled with ^^P using oligonucleotide labeling (Amersham Corp., Arlington 
Heights, III.). 
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RESULTS 
Bacteriology 
Seventy-five animals from four different herds were examined for the 
presence of Salmonella. Each herd had a different history of salmonellosis, 
ranging from no known previous exposure (herds 1 and 2) to intermittent 
infection (herds 3 and 4). Fecal cultures were 9/75 (12%) Salmonella 
positive, whereas 39/75 (52%) neutrophil cultures were positive for 
Salmonella. Salmonella isolated from the feces of five pigs in herds two and 
four were group B and group D Salmonella (not S- choleraesuis) and these 
pigs did not have salmonellae isolated from their neutrophils. Group four 
had four pigs with positive fecal and neutrophil cultures, but contained group 
D salmonellae (S. enteritidis) in feces, and group C, salmonellae (g. 
choleraesuis) in neutrophils (Table 1). 
Three animals from group 1 and group 4, which were neutrophil 
positive for S. choleraesuis had feces, buffy coat and neutrophil samples 
repeatedly cultured to examine for reproducibility and for optimal neutrophil 
numbers for Salmonella isolation. Samples were collected on at least three 
separate occasions and low numbers of salmonellae were consistently found 
from the animals in group 4 (pig number 281, 297,and 300) (Table 4). 
Some animals had salmonellae isolated from the undiluted neutrophil sample 
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(25 X 10° PMN) whereas in otliers, Salmonella isolations were made from 
10 ^  and 10^ dilutions of neutrophils (25 X 10® and 25 X 10'^ PMN, 
respectively) (Table 4). Buffy coat cultures from these pigs were also 
cultured in an attempt to isolate bacteria. Group 1 pigs had only 10% (100 
//I containing 10 X 10® wbc) of their buffy coat inoculated into peptone 
water, and group 4 pigs had the entire buffy coat (100%) from 50 ml of 
blood (>100 X 10® total cells with 38-49% neutrophils) inoculated into 
peptone water. All buffy coats from group 1 pigs were Salmonella negative, 
but group 4 animals were 93% positive by this method when compared to 
the cultures of neutrophils only (Table 4). This may indicate variability in 
Salmonella levels between animals from groups 1 and 4, as well as the 
advantage of culturing large (>10® wbc) amounts of buffy coat to increase 
the frequency of Salmonella isolation. 
Following necropsy of the neutrophil positive pigs from groups 1 and 
4, ten organs, four lymph nodes, bone marrow and blood samples were 
examined for the presence of salmonellae. All organs examined were 
negative except for one animal in group 1, which had a Salmonella group D 
organism (unrelated to &. choleraesuis) isolated from its lung (Table 3). 
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Plasmid DNA analysis 
The 50 Icb plasmid of S- choleraesuis fias been siiown to be required 
for virulence and invasion of tiie intestinal epithelium. DNA analysis by 
agarose electrophoresis and Southern blot indicated that all the isolates 
examined, except for avirulent strain 38 PMNa-5X contain the 50 kb plasmid 
(Figure 1). 
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DISCUSSION 
The ability of salmonellae to resist phagocyte killing has been well 
documented (2,6,8,10,11,16,18,19). The importance of the phagocyte, 
especially the neutrophil. In Salmonella control has also been examined, but 
this report describes the role of neutrophils as a source for persistent 
Salmonella infection and identification of Salmonella positive carrier animals. 
The frequency of Salmonella isolation from the neutrophils compared 
to fecal isolation was unexpected and indicates that neutrophils may be the 
best source of culture material for detecting carrier animals. There are 
several possible reasons why Salmonella was not isolated from fecal 
samples, including; the present enrichment methods used to isolate 
salmonellae from fecal samples may not adequately identify positive animals, 
chronically infected or carrier animals may not shed detectable numbers of 
Salmonella in feces, competitive inhibition from normal flora may limit the 
usefulness of fecal samples for Salmonella screening, and antibiotic levels 
currently used in the field may prevent isolation of salmonellae from feces. 
These data may indicate that neutrophil or buffy coat samples should be 
cultured if salmonellosis is suspected in swine. 
Another important aspect of this investigation is the frequency of §. 
choleraesuis isolation specifically from the neutrophils. This may suggest 
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that S. choleraesuis uses phagocytes as intracellular reservoirs of infection in 
its pathogenesis. Neutrophils have a half-life of only 6-8 h in the blood and 
therefore are relatively short lived cells (4). Most neutrophils apparently 
pass through the gut for removal from the body (4), and intracellular 
salmonellae could then be released back into the intestinal environment. 
This may explain the recurrence of salmonellosis in infected herds and 
explain a mechanism for the carrier state, as well as the difficulty in 
treatment. Orally administered antibiotics that are not absorbed from the 
gut, would have no influence on the carrier state. 
Earlier research has found some evidence to indicate that the large 
virulence plasmid may be lost following repeated neutrophil exposure (13). 
From the seven isolates examined, there is no evidence to support this 
occurrence in vivo, suggesting that the maintenance of this plasmid in vivo 
is important for virulence. 
It was found that lysis of neutrophils and inoculation into the peptone 
water resulted in higher success rates of Salmonella isolations, compared to 
direct plating on MacConkey media. It is possible that lysis of the 
neutrophils and then dilution into peptone media caused the dilution of 
bactericidal and bacteriostatic granular contents and then allowed growth of 
low numbers of salmonellae. 
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There were no fecal isolation of salmonellae from pigs in group 3, but 
there were numerous isolations from buffy coat and neutrophil samples. 
This group did not have salmonellosis at the time of sampling and was on 
medication (Carbadox) prior to the time of sampling. The Isolation of g. 
choleraesuis from 67% of the neutrophil samples, but none from feces 
cultures may be due to prior treatment with Carbadox. 
Isolation of Salmonella from group 2, a healthy herd with no history of 
salmonellosis may be important and may indicate the prevalent distribution 
of Salmonella throughout the swine population. Future attempts at 
Salmonella isolation may require additional sample examination, as well as 
improved culture procedures. 
From the data presented, the following conclusions can be made: 1} 
S. choleraesuis can be more efficiently and frequently isolated from porcine 
neutrophils than from other samples. 2) Purified neutrophils or large amounts 
of buffy coat should be an alternative or supplemental sampling source when 
salmonellosis is suspected, 3) S- choleraesuis may be isolated from 
neutrophils of animals with no history of clinical salmonellosis and; 4) 
neutrophils may be an important reservoir in the maintenance of the carrier 
state of S. choleraesuis in swine. 
Table 1. Isolation of : Salmonella from feces. blood, buffy coat and purified leukocyte 
populations of healthy pigs' 
Group No. of pias with Salmonella Samples 
Total No. examined feces blood 1 buffy coat*" MN leuk' PMN 
1 3/3 — — — — + 
2 3/24 +•= - — — — 
4/24 — — — — +" 
3 4/24 - + + + 
16/24 - - + + 
2/24 - + — — + 
1/24 - + + 
1/24 — — + 
4 4/24 +" + + + 
3/24 - - + + 
3/24 - - — — + 
1/24 - - + -
2/24 
* All positive cultures (+) were S. choleraesuis except those indicated. 
10% of the huffy coat isolated from 50 ml of blood. 
'2/3-S. enteritidis and 1/3 S. tvphimurium. 
""3/4-5. tvphimurium and 1/4-S, enteritidis. 
:2/2-S. enteritidis 
'mononuclear leukocytes isolated from 45-70% percoll interface 
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Table 2. Percentage of Salmonella positive samples from various 
sources 
Total positive fecal blood buffy coat MN PMN 
animals 
47/75 9/75' 11/75 30/75 0/75 39/75 
(63%) (12%) (15%) (40%) (0%) (52%) 
* None of the fecal isolations were S. choleraesuls fTable l). 
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Table 3. Analysis for the presence of Salmonella in 
selected pigs which had S. choleraesuis in their 
neutrophils 
Group 1' 
36 66 69 
Group 4, 
281 297 300 
Fecal 
PMN 
blood 
buffy coat 
Mononuclear 
Ascending colon 
Descending colon 
Ileum 
Spleen 
Liver 
Kidney 
Lung 
Ileo-cecal valve 
Ileo-cecal LN 
Colonic LN 
Tonsil 
Retropharyngeal LN 
Tracheobronchial LN 
Bone Marrow 
+ 
+ 
+ 
+ 
+ 
+ 
• 10% of the buffy coat isolated from 50 ml of blood. 
•' Entire (100%) buffy coat isolated from 50 ml of blood. 
' group D Salmonella 
LN = lymph node 
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Table 4. Repetitive analysis of blood samples which were 
positive for S. choleraesuls isolation from PMN samples 
Pig No. repl rep2 rep3 rep4 rep5 
3 6 Buffy coat* - - - - ND 
PMN + — — ND ND 
66 Buffy coat' — - - - ND 
PMN — + — — ND 
69 Buffy coat* - - - - ND 
PMN + — + + ND 
281 Buffy coat*" + + + + + 
PMN + (-2) + (-1) + (-2) + (-2) + 
297 Buffy coat*" + + + + + 
PMN + + (-1) + + (-1) + 
300 Buffy coat'' + + - + + 
PMN + + (-1) + + + 
original samples (indicated by + containing 25 X 10* PMN/ml) were 
still positive for Salmonella. 
• Group 1-100 ul sample (10%) from the buffy coat isolated from 
50 ml of blood. 
Group 4-the entire buffy coat (100%) isolated from 50 ml of 
blood (>100 X 10 ® WBC/ml) 
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A  a b c d e F g h  
Figure 1. Plasmid analysis of S. choleraesuis from in vivo neutropiiil 
isolates. Figure A (top) is an agarose gel (0.5%) stained with 
ethidium bromide and Figure B (bottom) is the corresponding 
Southern blot using the 50 kb virulence plasmid as a probe. 
Lane a contains plasmid DNA from strain 38 PMNa-5X (cured of 
50 kb plasmid). Lanes b-h contain strain 38, isolate from pig 
36, isolate from pig 69, isolate from group 3, isolate from pig 
281, isolate from pig 297, and isolate from pig 300, 
respectively. 
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ABSTRACT 
The mechanisms of invasion used by virulent and avirulent Salmonella 
choleraesuis were compared using a Vero cell invasion assay. Virulent S. 
choleraesuis strain 38 and avirulent stain 9 were examined for their ability to 
invade and survive in Vero cells. The assay was performed by 
S. choleraesuis infection of the Vero cell monolayer alone and in the 
presence of various treatments applied to the Vero cell monolayers. 
Intracellular S. choleraesuis colony forming units were then determined to 
characterize the mechanism of bacterial uptake. Invasion was not affected 
by colchicine, but was significantly inhibited in the presence of cytochalasin 
B and D, chloroquine, and dansylcadaverine. Inhibition by the above 
substances suggested the importance of microfilaments and of receptor 
recycling in receptor-mediated endocytosis. Both bacterial strains had 
decreased invasion in the presence of mannose and after enzymatic 
treatment of the bacteria with trypsin. Mannose exposure caused a 
decrease (48%) in the uptake of virulent S. choleraesuis 38 and a 28% 
decrease in avirulent S. choleraesuis 9. Inhibition of endosome acidification 
did not affect intracellular survival of virulent strain 38 as much as it 
affected the avirulent strain 9. Results from these experiments suggested 
that Vero cell invasion by S. choleraesuis was mediated by the host cells via 
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receptor-mediated endocytosis, and was mediated in part by mannose-
sensitive adhesins. Outer membrane proteins were extracted from the 
virulent and avirulent strain and compared on SDS-PAGE following surface 
protein labeling with '^®l. Virulent S. choleraesuis 38 had a unique 35 kDa 
protein. The outer membrane proteins of both strains were then examined 
by radioimmunoprecipitation and Western blot analysis using guinea pig 
polyclonal antisera. The 35 kDa protein was again found to be unique to the 
virulent strain 38. Antisera against the 35 kDa protein significantly inhibited 
invasion of Vero cells by S. choleraesuis strain 38. 
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INTRODUCTION 
In order to initiate infection. Salmonella choleraesuis must attach to and 
invade mucosal surfaces, replicate, and survive within phagocytes (3). 
Several bacterial species are capable of surviving macrophage and neutrophil 
ingestion (4,5,6,21,24,27). Phagocytes release viable bacteria which can 
then spread to lymphoid follicles, the spleen, the kidneys and the circulatory 
system (28). 
The translocation of bacteria across intestinal epithelium appears to be 
an important first step in infection with shigellae, yersiniae, enteroinvasive 
Escherichia coli (EIEC), and salmonellae. Invasion appears to be initiated by 
irreversible receptor-mediated attachment to epithelial cells, endocytic 
uptake, and then vacuole transfer and release into the lamina propria where 
the bacteria are ingested by phagocytes (7,26). 
A tissue culture model developed by Giannella et al. (10) compared 
invasion of HeLa cells with invasion of rabbit intestinal mucosal cells. The 
results revealed the two models to be similar. Infection of HeLa cells was by 
a process similar to phagocytosis in which bacteria became attached to 
microvilli and were then taken into a vacuole (20). 
The invasion of HeLa cells by S. tvohimurium required irreversible 
attachment and was accomplished by mannose-resistant (MR) adhesins 
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other than type 1 fimbriae (18,19). Morphologic studies determined that 
attachment to microvilli occurred rapidly in HeLa cell invasion, with 
subsequent shortening of the microvilli which allowed bacteria-cell 
attachment. The bacteria were then enclosed in a membrane-lined vesicle. 
Infective §. typhi were then able to multiply in this vesicle (29). 
Recent work by Finlay et al. (9) has demonstrated that g. choleraesuis 
invasion of Madin Darby Canine Kidney (MDCK) cells is an active process 
requiring bacterial RNA and protein synthesis. The bacteria were internalized 
within a membrane bound vacuole and penetrated through the MDCK 
monolayers. This adherence and invasion was an inducible event. The 
induction required cell-to-cell contact between the bacteria and the epithelial 
cells (9). The ability to attach and invade appeared to be closely linked 
events. Surface protein mutants of the invasive S. choleraesuis were 
generated using transposon TnphoA. Mutants unable to penetrate the 
monolayers were also unable to adhere to the epithelial cells. The mutations 
were not in the region encoding for type 1 pili or mannose-resistant 
hemagglutinins (8). 
Recent tissue culture models examined the different invasion strategies 
of EIEC, salmonellae, yersiniae, and shigellae using various cell culture 
monolayers (15,26). In contrast to the above work with different genera, 
the investigation reported here was designed not to identify specific 
I l l  
virulence determinants, but rather characterize differences between virulent 
and avirulent strains of S. choleraesuis and their differences in invasion, 
outer membrane proteins (OMP), and possible role in pathogenesis. 
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MATERIALS AND METHODS 
Bacterial strains 
Virulence of g. choleraesuis was characterized by determining the 
LD50 In Swiss-Webster mice following foot-pad injection. Virulent strain 38 
LD50 was 1.1 X 10^ CFU/ml and avirulent strain 9 LD50 was >10^ CFU/ml. 
These strains also differed significantly In their susceptibility to bactericidal 
activity by porcine neutrophils, and sensitivity to complement, with strain 38 
being resistant and strain 9 relatively sensitive (12,13,14,24). These strains 
both have a smooth LPS and identical numbers of plasmlds (data not 
shown). These S. choleraesuis strains and one E. coj] K99 control were 
strealced onto brain heart Infusion (BHI) (DIfco, Detroit, Ml, U.S.A.) agar and 
incubated at 37 C for 12 hours. Isolated colonies were transferred to BHI 
broth for two hours at 37 C. Bacteria were pelleted by centrifugation, and 
resuspended in Dulbecco's Minimum essential media (DMEM) to an O.D. of 
0.20 at 540 nm (2 X 10® cells/ml). These cells were then used at this 
concentration In all cell culture assays. 
Cell culture 
African Green Monkey kidney (Vero) cells were maintained in 
Dulbecco's Modified Eagle's Medium (DMEM) (SIGMA) containing 10% fetal 
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bovine serum (GIBCO), streptomycin (0.50 mg/ml) (Pfizer, Inc., N.Y.), 
fungizone (5 //g/ml), and penicillin (500 units/ml) (Squibb and Sons, Inc., 
Princeton, N.J.). Each well of an 8-well culture plate was inoculated with 1 
X 10*^ Vero cells and incubated in 5% COg, at 37 C, and 98% humidity for 
24 hours to establish confluent monolayers. 
Determination of Salmonella invasion of Vero cells 
Vero cells were cultured in 8-well (26 X 33 mm) Lux plates (LAB-TEK, 
Miles Lab., Inc., Naperville, IL). Prior to addition of the Vero cells, some 
plates had glass coverslips placed in half of the wells to allow monolayer 
formation onto the coverslips. Freshly prepared salmonellae (500//I) were 
added to each well in a ratio of 1000:1 bacteria to Vero cells. After two 
hours incubation wells were washed three times with DMEM containing 100 
/yg/ml gentamicin to kill all extracellular bacteria. Coverslips were removed 
at various time intervals, Wright-Giemsa stained (Diff-Quick stain, American 
Scientific Products, McGaw Park, IL) and examined for infection of cells. 
Wells without a coverslip were incubated for an additional two hours with 
the DMEM containing gentamicin. The supernatants were examined for 
sterility by plating onto BHI agar. The wells were washed an additional three 
times with DMEM to remove gentamicin, and the cell monolayers were lysed 
using 0.10% sodium dodecyl sulfate (SDS), releasing all intracellular 
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bacteria. Samples from each well were then diluted in a phosphate buffered 
saline solution (PBSS) and plated in quadruplicate to determine the number 
of CPUs present. The results were then expressed as the mean and 
standard error of the mean of five experiments. 
Treatment of Vero cells with functional inhibitors 
One hour prior to the addition of bacteria, the appropriate inhibitor 
was added to each well and allowed to incubate for one hour. The inhibitors 
(Sigma Chemical Co., St. Louis, MO) were chloroquine (200 //g/ml), 
dansylcadaverine (SOOywM), cytochalasin B (5 //g/ml), cytochalasin D (0.50 
//g/ml), and colchicine (5//g/ml). Mannose (1%) and trypsin (2 mg/ml) 
(Sigma Chemical Co., St. Louis, MO). These inhibitors were incubated with 
the bacterial preparation for one hour before inoculation onto the 
monolayers. The assay was then performed as described for the invasion 
assay using DMEM alone as an inhibitor control. Data were then expressed 
as the ratio of the treatment means and standard error of the mean. Four 
experiments were each done in quadruplicate, and then compared to the 
untreated control. 
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Invasion inhibition assay 
Heat-inactivated polyclonal guinea pig antisera against choleraesuis 
strain 9 and 38 whole cells, sarcosyl purified outer membrane protein (OMP), 
and the unique 35 kDa OMP from strain 38 were incubated with the 
Salmonella. The antibody coated bacteria were then incorporated into the 
invasion assay as previously described. 
Outer membrane protein preparation 
Outer membrane proteins were isolated as previously described (2). 
Briefly, bacterial cultures were grown on trypticase soy agar (TSA) (Difco, 
Detroit, IVII, U.S.A.) for 12 h at 37 C, washed off the plates with PBS, and 
harvested by centrifugation. Cultures were washed three times with PBSS 
and resuspended in lOmM HEPES. Bacterial suspensions were then placed 
on ice and sonicated for two minutes in 15 second pulses, centrifuged to 
remove cellular debris and the supernatant was then collected. This 
supernatant was centrifuged at 100,000 x g for two h. The resulting pellet 
was extracted for 30 minutes with 2% laurylsarcosine (Sigma Chemical Co., 
St. Louis, iVIO, U.S.A.) and then centrifuged for an additional two h at 
100,000 X g. The laurylsarcosine extraction was then repeated. The 
resulting pellet was resuspended in distilled water, protein concentration was 
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determined using the BCA Protein Assay (Pierce, Rockford, IL, U.S.A.) and 
frozen at -70 C. 
Radlolabeling of OMPs 
Labeling of OMPs of the purified preparation and of washed whole 
cells was done using lodo-Beads (Pierce, Rockford, IL, U.S.A.) as described 
previously (23). 
OMR analysis 
OMP and exposed surface proteins of whole cells were analyzed using 
SDS-PAGE as described by Laemeli (22) using unstained molecular mass 
standards (Amersham, New Heights, IL, U.S.A.). Radioimmunoprecipitation 
and Western blots were performed using guinea pig and rabbit antisera as 
described (1). Protein G (Amersham, New Heights, IL, U.S.A.) was used to 
detect antigen-antibody complexes labeled with ^^^lodine as a probe. 
Western blots were performed following protein transfer to nitrocellulose 
(Schleicher & Schuell, Inc., Keene, N.H., U.S.A.) and using guinea pig sera. 
Immunoblots were incubated in horseradish peroxidase-conjugated goat anti-
guinea pig immunoglobulin (1:1000) and then visualized with TMB 
membrane peroxidase substrate (Kirkegaard and Perry, Gaithersburg, MD, 
U.S.A.). 
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Preparation of antisera 
Rabbits and guinea pigs were immunized by the procedure previously 
described (1), using Freund's complete adjuvant, followed by a booster in 
Freund's Incomplete adjuvant. The immunogens used included 
S. choleraesuis strain 9 and strain 38 whole cells washed three times in 
PBSS (100 jul of 2 X 10® CFU/ml), purified OMP (100//g protein/ml), and a 
35 kDa protein (25 //g/ml) that was obtained by chromatography, as 
described below. Guinea pig sera were, heat-inactivated at 56 C for 60 min, 
and then precipitated using 50% ammonium sulfate (1). The antiserum 
against the 35 kDa protein was examined by radioimmunoprecipitation using 
iodinated strain 38 OMP and found to be monospecific for this 35 kDa 
protein. 
Affinity Chromatography 
Columns were prepared using AFFI-PREP 10 affinity columns (Bio-Rad, 
Richmond, CA, U.S.A.). The affinity matrix was coated with the antiserum 
against avirulentS- choleraesuis 9 OMP, and then labeled virulent 
S. choleraesuis 38 OMP antigen was passed over the column. Fractions 
were collected in 1 ml aliquots and analyzed by SDS-PAGE to determine 
antigens not removed by the antiserum. These fractions contained the 35 
kDa protein and were used as immunogens as previously described. Antigen 
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bound to the column was then eluted and also analyzed by SDS-PAGE. This 
was also done using OMR from the avirulent strain 9 passed over an 
affinity column coated with antiserum against virulent strain 38. 
Statistical analysis 
Statistical significance was determined using a F-test and a Students' 
distribution (t-test) to determine significance. 
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RESULTS 
Invasion by virulent and avirulent g. choleraesuis 
Vero cell monolayers were infected with virulent S. choleraesuis 38, 
avirulent S- choleraesuis 9 and non-invasive call K99 to compare their 
uptake by Vero cells. The numbers of choleraesuis recovered from Vero 
cells after two h of infection followed by two h of gentamicin treatment 
were compared (Table 1). Uptake of virulent S. choleraesuis 38 by Vero 
cells was more efficient than the avirulent strain 9. E. goji K99 was isolated 
at a rate of only 1.7 X 10° CFU/ml and used as a non-invasive control. The 
two h infection of Vero cells was required for optimal invasion by g. 
choleraesuis. and gentamicin treatment for two h insured elimination of all 
viable extracellular bacteria. Observations of the Wright-Giemsa stained 
coverslips (data not shown) were consistent with the data presented in 
Table 1. 
Role of microfilaments and microtubules in invasion 
The role of the Vero cell cytoskeleton in S. choleraesuis invasion was 
examined by selective inhibition of microfilament and microtubule function. 
The microfilament inhibitors cytochalasin B and D (11,17,25) caused 
significant inhibition of virulent and avirulent S. choleraesuis invasion. The 
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microtubule inhibitor colchicine (11) had no effect on the invasion of virulent 
or avirulent strains of S* choieraesuis (Figure 1). 
Receptor recycling and endosome acidification 
The ability of Vero cells to recycle surface receptor components was 
studied by examining the effects of dansylcadaverine (7) and chloroquine 
(17) on S. choieraesuis invasion. Both treatments caused significant 
inhibition of invasion by both virulent and avirulent S- choieraesuis. 
Chloroquine also prevents endosome acidification (17). The virulent S. 
choieraesuis 38 remained significantly (P<0.01) more invasive in the 
presence of chloroquine than did the avirulent strain 9 (Figure 1). 
Bacterial attachment 
Bacteria were pre-treated with mannose and trypsin to determine their 
effects on attachment. Mannose blocks type 1 fimbriae-mediated adhesion 
(18,19) and inhibited adherence of both virulent and avirulent strains of S. 
choieraesuis. Attachment by virulent strain 38 was significantly (P<0.01) 
more inhibited than the avirulent strain 9. Trypsin treatment was done to 
determine the enzymatic effect on S. choieraesuis surface proteins. Trypsin 
slightly inhibited adherence of both virulent and avirulent S. choieraesuis 
(Figure 1). 
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OMP analysis 
The OMP profiles obtained are shown in Figure 2. Initial results 
indicated that both virulent and avirulent strains had virtually identical OMP 
profiles with the exception of the region between 29 and 43 kDa. After 
S. choleraesuis 38 ^"1 labeled OMP were passed over the affinity column 
with antibody against avirulent strain 9, only an OMP of 35 kDa was not 
bound to the column and recovered. This protein was again isolated after 
repeated passage through the affinity column (Figure 3,). The antigen bound 
to the affinity columns was then eluted. Columns containing antiserum 
against strain 9 and 38 OMP contained small quantities of the 35 kDa and 
37 kDa proteins respectively, indicating weak cross-reactivity between these 
two proteins. 
Antibodies against the 35 kDa protein as well as antibodies against 
OMP from strain 9 and 38 were then used to coat bacterial surface proteins. 
Precipitated immunoglobulins were used at a concentration of 100 /yg/ml and 
incubated with the bacteria for one hour at 4 C. The immunoglobulin-coated 
bacterial strains were then used in the Vero cell invasion assay as described. 
Strains 9 and 38 both had significant (P<0.01) decreases in their level of 
invasion when coated with antiserum against OMP of 9 and 38 respectively 
(Figure 4). Antibodies against the 35 kDa OMP from strain 38 significantly 
inhibited (P<0.01) invasion of only the virulent strain 38. However, 
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immunoprecipitation (data not shown) and Western blot analysis (Figure 5) 
revealed some cross-reaction between antibody against the 35 kDa protein 
of strain 38 and the 37 kDa protein on strain 9. 
Vero cell invasion by the avirulent strain 9 was blocked only by 
homologous antibodies. Invasion of Vero cells by the virulent strain 38 was 
significantly (P<0.01) reduced by all antisera. It should by noted that the 
intrinsic invasive capability of these two strains differed at least 20 fold. 
Inhibition by antibodies is therefore not necessarily comparable and results 
may not be comparable between less invasive avirulent strain 9 and highly 
Invasive strain 38. 
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DISCUSSION 
Numerous investigators have examined the invasion strategies used by 
different species of enteric bacteria (7,15,26). The purpose of this 
investigation was to identify differences in the invasion of virulent and 
avirulent clinical isolates of S. choleraesuis. 
Cell monolayers have been extensively used to study bacterial invasion. 
Most investigators have used HeLa cells for Shigella. Yersinia, and 
Salmonella invasion studies. This research was conducted using similar 
procedures except that a Vero cell line was used as the invasion model. 
Other cell types including Chinese hamster ovary (CHO) and MDCK cells, 
used by Finlay and Falkow (7), were examined, but the Vero cells were 
chosen because of their rapid growth and affinity for Salmonella endocytic 
uptake. 
Motility and ingestion by phagocytic and non-phagocytic cells can be 
inhibited by disruption of the actin polymers of microfilaments by 
cytochalasins. Invasion by virulent and avirulent strains was virtually 
eliminated in the presence of cytochalasins. This suggested that infection of 
Vero cells is dependent on host cell function. Salmonella choleraesuis 
uptake is by receptor mediated endocytosis rather than cellular penetration. 
Microtubules did not play a part in cellular invasion as indicated by the 
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ineffectiveness of colchicine treatment. These observations are consistent 
with results obtained by Hale et al. (15) and Finlay et al. (7). 
After receptor mediated endocytosis, S. choleraesuis enters ceils in a 
membrane bound vacuole. The internal pH of the endosome is lowered 
causing dissociation of the receptor-ligand complex (17). Dansylcadaverine 
and chloroquine inhibit receptor recycling (7). Dansylcadaverine prevents 
receptor clustering (7), and chloroquine, a lysosomotropic agent, prevents 
receptor-ligand dissociation (17). Inhibition of receptor recycling drastically 
reduced both virulent and avirulent S. choleraesuis invasion. Inhibition of 
endosome acidification also reduced endocytosis of both strains of 
S. choleraesuis. but avirulent strain 9 was significantly more affected than 
virulent g. choleraesuis 38. 
These observations indicated that the invasion process is by receptor 
mediated endocytosis, involving microfilaments of the cell. Jones et al. (18) 
determined that irreversible attachment was required for S. tvphimurium 
invasion. Jones et al. (19) then determined this attachment to be mannose-
resistant and mediated by an adhesin other than Type 1 fimbriae. Finlay et 
al. (9) observed that 4-8 hours after infection, inducible adhesive proteins 
specific for the eukaryotic cell were expressed. Our observations suggested 
that endocytosis of both S. choleraesuis 9 and 38 was significantly inhibited 
by mannose, but that invasion by virulent S. choleraesuis 38 was inhibited 
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significantly more than avirulent S. choleraesuis 9. Mannose-sensitive 
adhesins may be important in the initial attachment of virulent g. 
choleraesuis 38 which then allows the interaction of cell-specific adhesive 
proteins (18). 
Hale et al. (16) have noted that invasion by Shigella was reduced in the 
presence of enzymatic treatment mimicking that of the intestine. They 
suggest that this enzymatic treatment may alter the outer membrane of 
salmonellae enabling increased invasion. We found this not to apply to S. 
choleraesuis. Trypsin treatment of S. choleraesuis inhibited both virulent 
and avirulent strains, decreasing invasion to 79% and 66% of controls. 
It appears that the virulent S. choleraesuis 38 constitutively expressed 
a 35 kDa protein that was not detectable in the avirulent strain. Antibody 
against this protein inhibited invasion, demonstrating that it may have a role 
in receptor mediated uptake. It may not be the sole element involved, 
however. Finlay et al. (8) demonstrated that LPS of smooth strains of 
Salmonella are necessary for invasion. Some of the inhibition of invasion 
observed may have been due to LPS contamination of the OMP antigen and 
resultant antibodies to LPS. Antisera against the entire OMP profile were 
more effective in blocking invasion than was antiserum against the 35 kDa 
protein alone. This, along with evidence supplied by Finlay et al. (9), 
demonstrates that bacterial OMP may play a role in the pathogenesis of 
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virulent bacteria. Western blot analysis of these outer membrane proteins 
using antisera against the 35 kDa OMP of the virulent strain 38 revealed 
that the 35 kDa protein did cross-react with a 37 kDa protein found on 
avirulent strain 9 (Figure 5). Polyclonal antisera against strain 9 and 38 
OMP both reacted with the 35 kDa protein of the virulent strain and 37 kDa 
of the avirulent strain. This may indicate that a unique 35 kDa protein is 
expressed on the virulent strain 38 at a high level (compared to the 37 kDa 
protein), and that the 35 kDa protein shares some degree of homology with 
the 37 kDa protein of the avirulent strain. The ability of antiserum to inhibit 
invasion of strain 38 and not strain 9 may indicate that this protein is 
necessary for receptor mediated endocytosis of strain 38 only. 
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Table 1. Recovery of S. choleraesuis strains 9 and 38 in 
supernatants from lysed Vero cells 
CFU/ml JLSEM X 10^' 
S. choleraesuis 9 S. choleraesuis 38 
(Avirulent) (Virulent) 
Vero Cell invasion 2.2 jL 1.7" 52.0 zL 14.0" 
"mean ±_ standard error of the mean of five or more experiments, 
^significant differences (P < 0.01) between strains 9 and 38. 
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80 
6 0 - -
40- -
20 -
0 
fîl 
** 
_È 
•+ 
•t 
C3SCS 9 
Ksascs 38 
n, iSL -jdEal 
coich chloro dans mann tryp cytb cytd 
• - indicates treatment is significantly different (P<0.01) from 
the untreated control. 
** -indicates differences between virulent S. choleraesuis 38 
and avirulent S. choleraesuis 9 (P<0.01). 
FIGURE 1. Effect of various treatments on Salmonella choleraesuis 
invasion of Vero cell monolayers. Treatments include: 
colchicine (colch), chloroquine (chloro), dansylcadaverine 
(dans), mannose (mann), trypsin (tryp), cytochalasin B (cytb), 
and cytochalasin D (cytd). Results expressed as the percent of 
treatmentxontrol. Values shown are the mean plus standard 
error of quadruplicate samples from 4 experiments. 
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Figure 2. Outer membrane profiles of S. choleraesuis strains 38 (lane 1 ) 
and 9 (lane 2). Sarcosyl extracted outer membrane proteins 
were labeled with ^^®l and analyzed by SDS polyacrylamide gel 
electrophoresis (6-20% gradient). Virulent strain 38 expresses a 
unique 35 kDa protein. 
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Figure 3. Analysis of iodinated outer membrane proteins passed through 
an affinity column and unbound antigen was collected. Lane 1 is 
strain 38 OMP control. Lanes 2 and 3 are labeled strain 38 OMP 
after successive passages, respectively, over an affinity column 
containing antiserum against strain 9. Lane 4 is strain 9 OMP 
control. Lanes 5 and 6 are labeled strain 9 OMP after successive 
passages, respectively, through an affinity column containing 
antiserum against strain 38 (overexposed to insure that no 
protein was present). Only the unique 35 kDa protein was 
recovered from the affinity columns. 
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Strain 
Strain 38 
38 35<D anti-sera c 38 35I<D 
•• Significantly different {P<0.01) than the same strain of 
bacteria not exposed to antiserum. 
Figure 4. Effect of polyclonal antisera produced against strain 9 and 38 
OMP, and monospecific antiserum against the 35 kDa protein 
unique to strain 38 on Vero cell invasion. Controls (ctl) were 
treated with normal guinea pig serum. 
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-29 
Figure 5. Western blot analysis of strain 9 and 38 OMP profiles using 
antiserum against the 35 kDa protein and polyclonal antisera 
against strains 9 and 38 OMP. Lanes 1 and 2 are strain 38 OMP 
exposed to antiserum against strain 38 and 9 respectively. Lane 
3 and 4 are strains 38 and 9 OMP respectively exposed to 
antiserum against the 35 kDa protein. Lanes 5 and 6 are strain 
9 OMP exposed to antiserum against strain 38 and 9 OMP, 
respectively. The 35 kDa protein {< <) of strain 38 was 
recognized by the antiserum against the 35 kDa protein, but 
there was weak cross-reactivity with the 37 kDa (*) expressed 
on strain 9. 
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SUMMARY AND CONCLUSIONS 
From this research it can be concluded that the interaction of g. 
choleraesuis with porcine neutrophils is a significant phenomenon that needs 
to be considered when evaluating bacterial virulence mechanisms and 
detection of Salmonella in the host. Repeated neutrophil exposure has been 
demonstrated to induce a variety of changes which allow increased bacterial 
survival in the presence of phagocytes, expression of new outer membrane 
proteins involved in resistance to the immune system and cell invasion, and 
attenuation of an S. choleraesuis isolate. This suggests a possible in vitro 
assay which may be used to attenuate other bacterial isolates for future 
vaccines. Salmonella choleraesuis is a facultative intracellular pathogen, and 
in vivo, phagocytes must be considered as a reservoir when attempting to 
detect carrier animals. Results indicate neutrophils may be the best sample 
to examine when attempting to isolate S. choleraesuis. 
Salmonella choleraesuis is a complex pathogen capable of using many 
distinct virulence mechanisms to promote disease. The ability of the 
organism to adapt to the host immune response is a significant factor that 
must be considered when examining virulence determinants as well as 
protective immunity. These changes are significant because they may allow 
the identification of important immunogens, identify additional virulence 
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determinants, and may improve tiie diagnosis of S. ctioleraesuis in swine as 
well as other domestic animals. 
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